<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1994-02-01" modified="2020-10-07" version="247">
<accession>P35222</accession>
<accession>A8K1L7</accession>
<accession>Q8NEW9</accession>
<accession>Q8NI94</accession>
<accession>Q9H391</accession>
<name>CTNB1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Catenin beta-1</fullName>
</recommendedName>
<alternativeName>
<fullName>Beta-catenin</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">CTNNB1</name>
<name type="synonym">CTNNB</name>
<name type="ORF">OK/SW-cl.35</name>
<name type="ORF">PRO2286</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1994" name="J. Cell Biol." volume="127" first="2061" last="2069">
<title>E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton.</title>
<authorList>
<person name="Huelsken J."/>
<person name="Birchmeier W."/>
<person name="Behrens J."/>
</authorList>
<dbReference type="PubMed" id="7806582"/>
<dbReference type="DOI" id="10.1083/jcb.127.6.2061"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="2">
<citation type="submission" date="1999-02" db="EMBL/GenBank/DDBJ databases">
<title>Functional prediction of the coding sequences of 75 new genes deduced by analysis of cDNA clones from human fetal liver.</title>
<authorList>
<person name="Zhang C."/>
<person name="Yu Y."/>
<person name="Zhang S."/>
<person name="Wei H."/>
<person name="Bi J."/>
<person name="Zhou G."/>
<person name="Dong C."/>
<person name="Zai Y."/>
<person name="Xu W."/>
<person name="Gao F."/>
<person name="Liu M."/>
<person name="He F."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Fetal liver</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2003-11" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT VAL-688</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Hippocampus</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2006" name="Nature" volume="440" first="1194" last="1198">
<title>The DNA sequence, annotation and analysis of human chromosome 3.</title>
<authorList>
<person name="Muzny D.M."/>
<person name="Scherer S.E."/>
<person name="Kaul R."/>
<person name="Wang J."/>
<person name="Yu J."/>
<person name="Sudbrak R."/>
<person name="Buhay C.J."/>
<person name="Chen R."/>
<person name="Cree A."/>
<person name="Ding Y."/>
<person name="Dugan-Rocha S."/>
<person name="Gill R."/>
<person name="Gunaratne P."/>
<person name="Harris R.A."/>
<person name="Hawes A.C."/>
<person name="Hernandez J."/>
<person name="Hodgson A.V."/>
<person name="Hume J."/>
<person name="Jackson A."/>
<person name="Khan Z.M."/>
<person name="Kovar-Smith C."/>
<person name="Lewis L.R."/>
<person name="Lozado R.J."/>
<person name="Metzker M.L."/>
<person name="Milosavljevic A."/>
<person name="Miner G.R."/>
<person name="Morgan M.B."/>
<person name="Nazareth L.V."/>
<person name="Scott G."/>
<person name="Sodergren E."/>
<person name="Song X.-Z."/>
<person name="Steffen D."/>
<person name="Wei S."/>
<person name="Wheeler D.A."/>
<person name="Wright M.W."/>
<person name="Worley K.C."/>
<person name="Yuan Y."/>
<person name="Zhang Z."/>
<person name="Adams C.Q."/>
<person name="Ansari-Lari M.A."/>
<person name="Ayele M."/>
<person name="Brown M.J."/>
<person name="Chen G."/>
<person name="Chen Z."/>
<person name="Clendenning J."/>
<person name="Clerc-Blankenburg K.P."/>
<person name="Chen R."/>
<person name="Chen Z."/>
<person name="Davis C."/>
<person name="Delgado O."/>
<person name="Dinh H.H."/>
<person name="Dong W."/>
<person name="Draper H."/>
<person name="Ernst S."/>
<person name="Fu G."/>
<person name="Gonzalez-Garay M.L."/>
<person name="Garcia D.K."/>
<person name="Gillett W."/>
<person name="Gu J."/>
<person name="Hao B."/>
<person name="Haugen E."/>
<person name="Havlak P."/>
<person name="He X."/>
<person name="Hennig S."/>
<person name="Hu S."/>
<person name="Huang W."/>
<person name="Jackson L.R."/>
<person name="Jacob L.S."/>
<person name="Kelly S.H."/>
<person name="Kube M."/>
<person name="Levy R."/>
<person name="Li Z."/>
<person name="Liu B."/>
<person name="Liu J."/>
<person name="Liu W."/>
<person name="Lu J."/>
<person name="Maheshwari M."/>
<person name="Nguyen B.-V."/>
<person name="Okwuonu G.O."/>
<person name="Palmeiri A."/>
<person name="Pasternak S."/>
<person name="Perez L.M."/>
<person name="Phelps K.A."/>
<person name="Plopper F.J."/>
<person name="Qiang B."/>
<person name="Raymond C."/>
<person name="Rodriguez R."/>
<person name="Saenphimmachak C."/>
<person name="Santibanez J."/>
<person name="Shen H."/>
<person name="Shen Y."/>
<person name="Subramanian S."/>
<person name="Tabor P.E."/>
<person name="Verduzco D."/>
<person name="Waldron L."/>
<person name="Wang J."/>
<person name="Wang J."/>
<person name="Wang Q."/>
<person name="Williams G.A."/>
<person name="Wong G.K.-S."/>
<person name="Yao Z."/>
<person name="Zhang J."/>
<person name="Zhang X."/>
<person name="Zhao G."/>
<person name="Zhou J."/>
<person name="Zhou Y."/>
<person name="Nelson D."/>
<person name="Lehrach H."/>
<person name="Reinhardt R."/>
<person name="Naylor S.L."/>
<person name="Yang H."/>
<person name="Olson M."/>
<person name="Weinstock G."/>
<person name="Gibbs R.A."/>
</authorList>
<dbReference type="PubMed" id="16641997"/>
<dbReference type="DOI" id="10.1038/nature04728"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Skin</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2002" name="Cancer Res." volume="62" first="2744" last="2748">
<title>Oncogenic beta-catenin is required for bone morphogenetic protein 4 expression in human cancer cells.</title>
<authorList>
<person name="Kim J.-S."/>
<person name="Crooks H."/>
<person name="Dracheva T."/>
<person name="Nishanian T.G."/>
<person name="Singh B."/>
<person name="Jen J."/>
<person name="Waldman T."/>
</authorList>
<dbReference type="PubMed" id="12019147"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-312</scope>
</reference>
<reference key="9">
<citation type="submission" date="2001-05" db="EMBL/GenBank/DDBJ databases">
<title>Identification of immuno-peptidmics that are recognized by tumor-reactive CTL generated from TIL of colon cancer patients.</title>
<authorList>
<person name="Shichijo S."/>
<person name="Itoh K."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 258-781</scope>
<source>
<tissue>Colon adenocarcinoma</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="1994" name="FEBS Lett." volume="355" first="195" last="200">
<title>Distinct cadherin-catenin complexes in Ca(2+)-dependent cell-cell adhesion.</title>
<authorList>
<person name="Butz S."/>
<person name="Kemler R."/>
</authorList>
<dbReference type="PubMed" id="7982500"/>
<dbReference type="DOI" id="10.1016/0014-5793(94)01205-9"/>
</citation>
<scope>IDENTIFICATION IN AN E-CADHERIN/CATENIN ADHESION COMPLEX</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1997" name="Nat. Genet." volume="15" first="170" last="174">
<title>Promoter swapping between the genes for a novel zinc finger protein and beta-catenin in pleiomorphic adenomas with t(3;8)(p21;q12) translocations.</title>
<authorList>
<person name="Kas K."/>
<person name="Voz M.L."/>
<person name="Roeijer E."/>
<person name="Astroem A.-K."/>
<person name="Meyen E."/>
<person name="Stenman G."/>
<person name="Van de Ven W.J.M."/>
</authorList>
<dbReference type="PubMed" id="9020842"/>
<dbReference type="DOI" id="10.1038/ng0297-170"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH PLAG1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1999" name="Cancer Res." volume="59" first="918" last="923">
<title>Conserved mechanism of PLAG1 activation in salivary gland tumors with and without chromosome 8q12 abnormalities: identification of SII as a new fusion partner gene.</title>
<authorList>
<person name="Astroem A.-K."/>
<person name="Voz M.L."/>
<person name="Kas K."/>
<person name="Roeijer E."/>
<person name="Wedell B."/>
<person name="Mandahl N."/>
<person name="Van de Ven W."/>
<person name="Mark J."/>
<person name="Stenman G."/>
</authorList>
<dbReference type="PubMed" id="10029085"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH PLAG1</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="10173" last="10183">
<title>Phosphorylation and free pool of beta-catenin are regulated by tyrosine kinases and tyrosine phosphatases during epithelial cell migration.</title>
<authorList>
<person name="Mueller T."/>
<person name="Choidas A."/>
<person name="Reichmann E."/>
<person name="Ullrich A."/>
</authorList>
<dbReference type="PubMed" id="10187801"/>
<dbReference type="DOI" id="10.1074/jbc.274.15.10173"/>
</citation>
<scope>STIMULATION OF TYROSINE PHOSPHORYLATION BY EGF</scope>
<scope>DEPHOSPHORYLATION BY PTPRF</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2000" name="Nat. Struct. Biol." volume="7" first="800" last="807">
<title>Hot spots in beta-catenin for interactions with LEF-1, conductin and APC.</title>
<authorList>
<person name="von Kries J.P."/>
<person name="Winbeck G."/>
<person name="Asbrand C."/>
<person name="Schwarz-Romond T."/>
<person name="Sochnikova N."/>
<person name="Dell'Oro A."/>
<person name="Behrens J."/>
<person name="Birchmeier W."/>
</authorList>
<dbReference type="PubMed" id="10966653"/>
<dbReference type="DOI" id="10.1038/79039"/>
</citation>
<scope>INTERACTION WITH LEF1; APC; AXIN1; AXIN2 AND TCF7L2</scope>
<scope>PHOSPHORYLATION BY GSK3B</scope>
<scope>MUTAGENESIS OF PHE-253; HIS-260; LYS-292; LYS-345; TRP-383; ARG-386; ASN-426; LYS-435; ARG-469; HIS-470 AND LYS-508</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2001" name="Br. J. Dermatol." volume="145" first="576" last="581">
<title>Beta-catenin expression in pilomatrixomas. Relationship with beta-catenin gene mutations and comparison with beta-catenin expression in normal hair follicles.</title>
<authorList>
<person name="Moreno-Bueno G."/>
<person name="Gamallo C."/>
<person name="Perez-Gallego L."/>
<person name="Contreras F."/>
<person name="Palacios J."/>
</authorList>
<dbReference type="PubMed" id="11703283"/>
<dbReference type="DOI" id="10.1046/j.1365-2133.2001.04455.x"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
<scope>VARIANT PTR TYR-32</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2001" name="Genes Dev." volume="15" first="3342" last="3354">
<title>Chromatin-specific regulation of LEF-1-beta-catenin transcription activation and inhibition in vitro.</title>
<authorList>
<person name="Tutter A.V."/>
<person name="Fryer C.J."/>
<person name="Jones K.A."/>
</authorList>
<dbReference type="PubMed" id="11751639"/>
<dbReference type="DOI" id="10.1101/gad.946501"/>
</citation>
<scope>INTERACTION WITH LEF1</scope>
<scope>INHIBITION BY CTNNBIP1 BINDING</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="20436" last="20443">
<title>Regulation of beta-catenin structure and activity by tyrosine phosphorylation.</title>
<authorList>
<person name="Piedra J."/>
<person name="Martinez D."/>
<person name="Castano J."/>
<person name="Miravet S."/>
<person name="Dunach M."/>
<person name="de Herreros A.G."/>
</authorList>
<dbReference type="PubMed" id="11279024"/>
<dbReference type="DOI" id="10.1074/jbc.m100194200"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-86 AND TYR-654</scope>
<scope>INTERACTION WITH TBP</scope>
<scope>MUTAGENESIS OF TYR-654</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2001" name="J. Cell Sci." volume="114" first="3177" last="3188">
<title>AlphaT-catenin: a novel tissue-specific beta-catenin-binding protein mediating strong cell-cell adhesion.</title>
<authorList>
<person name="Janssens B."/>
<person name="Goossens S."/>
<person name="Staes K."/>
<person name="Gilbert B."/>
<person name="van Hengel J."/>
<person name="Colpaert C."/>
<person name="Bruyneel E."/>
<person name="Mareel M."/>
<person name="van Roy F."/>
</authorList>
<dbReference type="PubMed" id="11590244"/>
</citation>
<scope>INTERACTION WITH CTNNA3</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2001" name="Mol. Cell" volume="7" first="915" last="926">
<title>Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses.</title>
<authorList>
<person name="Matsuzawa S."/>
<person name="Reed J.C."/>
</authorList>
<dbReference type="PubMed" id="11389839"/>
<dbReference type="DOI" id="10.1016/s1097-2765(01)00242-8"/>
</citation>
<scope>INTERACTION WITH SIAH1</scope>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2001" name="Mol. Cell" volume="7" first="927" last="936">
<title>Siah-1 mediates a novel beta-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein.</title>
<authorList>
<person name="Liu J."/>
<person name="Stevens J."/>
<person name="Rote C.A."/>
<person name="Yost H.J."/>
<person name="Hu Y."/>
<person name="Neufeld K.L."/>
<person name="White R.L."/>
<person name="Matsunami N."/>
</authorList>
<dbReference type="PubMed" id="11389840"/>
<dbReference type="DOI" id="10.1016/s1097-2765(01)00241-6"/>
</citation>
<scope>INTERACTION WITH SIAH1</scope>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2001" name="Oncogene" volume="20" first="4249" last="4257">
<title>Genetic alteration of the beta-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion.</title>
<authorList>
<person name="Shigemitsu K."/>
<person name="Sekido Y."/>
<person name="Usami N."/>
<person name="Mori S."/>
<person name="Sato M."/>
<person name="Horio Y."/>
<person name="Hasegawa Y."/>
<person name="Bader S.A."/>
<person name="Gazdar A.F."/>
<person name="Minna J.D."/>
<person name="Hida T."/>
<person name="Yoshioka H."/>
<person name="Imaizumi M."/>
<person name="Ueda Y."/>
<person name="Takahashi M."/>
<person name="Shimokata K."/>
</authorList>
<dbReference type="PubMed" id="11464291"/>
<dbReference type="DOI" id="10.1038/sj.onc.1204557"/>
</citation>
<scope>INVOLVEMENT IN MESOM</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2002" name="Biochemistry" volume="41" first="15854" last="15860">
<title>Physical and functional interaction between receptor-like protein tyrosine phosphatase PCP-2 and beta-catenin.</title>
<authorList>
<person name="Yan H.-X."/>
<person name="He Y.-Q."/>
<person name="Dong H."/>
<person name="Zhang P."/>
<person name="Zeng J.-Z."/>
<person name="Cao H.-F."/>
<person name="Wu M.-C."/>
<person name="Wang H.-Y."/>
</authorList>
<dbReference type="PubMed" id="12501215"/>
<dbReference type="DOI" id="10.1021/bi026095u"/>
</citation>
<scope>INTERACTION WITH PTPRU</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2002" name="Biochem. Biophys. Res. Commun." volume="294" first="324" last="328">
<title>Characterisation of the phosphorylation of beta-catenin at the GSK-3 priming site Ser45.</title>
<authorList>
<person name="Hagen T."/>
<person name="Vidal-Puig A."/>
</authorList>
<dbReference type="PubMed" id="12051714"/>
<dbReference type="DOI" id="10.1016/s0006-291x(02)00485-0"/>
</citation>
<scope>PHOSPHORYLATION AT SER-45</scope>
<scope>CHARACTERIZATION OF VARIANT HEPATOCELLULAR CARCINOMA ALA-41</scope>
<scope>CHARACTERIZATION OF VARIANT DESMOID TUMOR ALA-41</scope>
<scope>CHARACTERIZATION OF VARIANT HEPATOBLASTOMA ALA-41</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2002" name="Cell" volume="110" first="789" last="799">
<title>Adenovirus fiber disrupts CAR-mediated intercellular adhesion allowing virus escape.</title>
<authorList>
<person name="Walters R.W."/>
<person name="Freimuth P."/>
<person name="Moninger T.O."/>
<person name="Ganske I."/>
<person name="Zabner J."/>
<person name="Welsh M.J."/>
</authorList>
<dbReference type="PubMed" id="12297051"/>
<dbReference type="DOI" id="10.1016/s0092-8674(02)00912-1"/>
</citation>
<scope>INTERACTION WITH CXADR</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2002" name="Exp. Cell Res." volume="276" first="264" last="272">
<title>Identification of two novel regulated serines in the N-terminus of beta-catenin.</title>
<authorList>
<person name="van Noort M."/>
<person name="van de Wetering M."/>
<person name="Clevers H."/>
</authorList>
<dbReference type="PubMed" id="12027456"/>
<dbReference type="DOI" id="10.1006/excr.2002.5520"/>
</citation>
<scope>PHOSPHORYLATION AT SER-23 AND SER-29 BY GSK3B</scope>
<scope>PHOSPHORYLATION AT THR-41</scope>
<scope>MUTAGENESIS OF SER-29</scope>
<scope>CHARACTERIZATION OF VARIANTS HEPATOCELLULAR CARCINOMA ARG-23; ALA-37 AND ALA-41</scope>
<scope>CHARACTERIZATION OF VARIANT PTR TYR-33</scope>
<scope>CHARACTERIZATION OF VARIANT MDB ALA-37</scope>
<scope>CHARACTERIZATION OF VARIANT DESMOID TUMOR ALA-41</scope>
<scope>CHARACTERIZATION OF VARIANT HEPATOBLASTOMA ALA-41</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="17901" last="17905">
<title>Wnt signaling controls the phosphorylation status of beta-catenin.</title>
<authorList>
<person name="van Noort M."/>
<person name="Meeldijk J."/>
<person name="van der Zee R."/>
<person name="Destree O."/>
<person name="Clevers H."/>
</authorList>
<dbReference type="PubMed" id="11834740"/>
<dbReference type="DOI" id="10.1074/jbc.m111635200"/>
</citation>
<scope>WNT SIGNALING MODULATES PHOSPHORYLATION</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2002" name="J. Cell Sci." volume="115" first="2771" last="2780">
<title>Regulation of S33/S37 phosphorylated beta-catenin in normal and transformed cells.</title>
<authorList>
<person name="Sadot E."/>
<person name="Conacci-Sorrell M."/>
<person name="Zhurinsky J."/>
<person name="Shnizer D."/>
<person name="Lando Z."/>
<person name="Zharhary D."/>
<person name="Kam Z."/>
<person name="Ben-Ze'ev A."/>
<person name="Geiger B."/>
</authorList>
<dbReference type="PubMed" id="12077367"/>
</citation>
<scope>PHOSPHORYLATION</scope>
<scope>INTERACTION OF PHOSPHORYLATED CTNNB1 WITH BTRC</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2002" name="Oncogene" volume="21" first="7067" last="7076">
<title>The transmembrane receptor protein tyrosine phosphatase DEP1 interacts with p120(ctn).</title>
<authorList>
<person name="Holsinger L.J."/>
<person name="Ward K."/>
<person name="Duffield B."/>
<person name="Zachwieja J."/>
<person name="Jallal B."/>
</authorList>
<dbReference type="PubMed" id="12370829"/>
<dbReference type="DOI" id="10.1038/sj.onc.1205858"/>
</citation>
<scope>INTERACTION WITH PTPRJ</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2002" name="Oncogene" volume="21" first="7861" last="7871">
<title>The emergence of protocadherin-PC expression during the acquisition of apoptosis-resistance by prostate cancer cells.</title>
<authorList>
<person name="Chen M.-W."/>
<person name="Vacherot F."/>
<person name="De La Taille A."/>
<person name="Gil-Diez-De-Medina S."/>
<person name="Shen R."/>
<person name="Friedman R.A."/>
<person name="Burchardt M."/>
<person name="Chopin D.K."/>
<person name="Buttyan R."/>
</authorList>
<dbReference type="PubMed" id="12420223"/>
<dbReference type="DOI" id="10.1038/sj.onc.1205991"/>
</citation>
<scope>INTERACTION WITH PCDH11Y</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2003" name="Hepatology" volume="38" first="178" last="186">
<title>EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma.</title>
<authorList>
<person name="Shibata T."/>
<person name="Chuma M."/>
<person name="Kokubu A."/>
<person name="Sakamoto M."/>
<person name="Hirohashi S."/>
</authorList>
<dbReference type="PubMed" id="12830000"/>
<dbReference type="DOI" id="10.1053/jhep.2003.50270"/>
</citation>
<scope>INTERACTION WITH SLC9A3R1</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2000" name="Biochem. Biophys. Res. Commun." volume="268" first="243" last="248">
<title>Regulation of beta-catenin signaling in the Wnt pathway.</title>
<authorList>
<person name="Kikuchi A."/>
</authorList>
<dbReference type="PubMed" id="10679188"/>
<dbReference type="DOI" id="10.1006/bbrc.1999.1860"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2003" name="Mol. Cell. Biol." volume="23" first="2287" last="2297">
<title>p120 Catenin-associated Fer and Fyn tyrosine kinases regulate beta-catenin Tyr-142 phosphorylation and beta-catenin-alpha-catenin Interaction.</title>
<authorList>
<person name="Piedra J."/>
<person name="Miravet S."/>
<person name="Castano J."/>
<person name="Palmer H.G."/>
<person name="Heisterkamp N."/>
<person name="Garcia de Herreros A."/>
<person name="Dunach M."/>
</authorList>
<dbReference type="PubMed" id="12640114"/>
<dbReference type="DOI" id="10.1128/mcb.23.7.2287-2297.2003"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-142 BY FYN</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2003" name="Nature" volume="422" first="905" last="909">
<title>Chibby, a nuclear beta-catenin-associated antagonist of the Wnt/Wingless pathway.</title>
<authorList>
<person name="Takemaru K."/>
<person name="Yamaguchi S."/>
<person name="Lee Y.S."/>
<person name="Zhang Y."/>
<person name="Carthew R.W."/>
<person name="Moon R.T."/>
</authorList>
<dbReference type="PubMed" id="12712206"/>
<dbReference type="DOI" id="10.1038/nature01570"/>
</citation>
<scope>INTERACTION WITH CBY1</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2004" name="Mol. Biol. Cell" volume="15" first="397" last="406">
<title>Novel membrane protein shrew-1 targets to cadherin-mediated junctions in polarized epithelial cells.</title>
<authorList>
<person name="Bharti S."/>
<person name="Handrow-Metzmacher H."/>
<person name="Zickenheiner S."/>
<person name="Zeitvogel A."/>
<person name="Baumann R."/>
<person name="Starzinski-Powitz A."/>
</authorList>
<dbReference type="PubMed" id="14595118"/>
<dbReference type="DOI" id="10.1091/mbc.e03-05-0281"/>
</citation>
<scope>INTERACTION WITH AJAP1</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="35">
<citation type="journal article" date="2006" name="Cancer Res." volume="66" first="723" last="728">
<title>TC1 (C8orf4) enhances the Wnt/beta-catenin pathway by relieving antagonistic activity of Chibby.</title>
<authorList>
<person name="Jung Y."/>
<person name="Bang S."/>
<person name="Choi K."/>
<person name="Kim E."/>
<person name="Kim Y."/>
<person name="Kim J."/>
<person name="Park J."/>
<person name="Koo H."/>
<person name="Moon R.T."/>
<person name="Song K."/>
<person name="Lee I."/>
</authorList>
<dbReference type="PubMed" id="16424001"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-05-3124"/>
</citation>
<scope>INTERACTION WITH CBY1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2006" name="Cancer Res." volume="66" first="10007" last="10015">
<title>E-cadherin regulates human Nanos1, which interacts with p120ctn and induces tumor cell migration and invasion.</title>
<authorList>
<person name="Strumane K."/>
<person name="Bonnomet A."/>
<person name="Stove C."/>
<person name="Vandenbroucke R."/>
<person name="Nawrocki-Raby B."/>
<person name="Bruyneel E."/>
<person name="Mareel M."/>
<person name="Birembaut P."/>
<person name="Berx G."/>
<person name="van Roy F."/>
</authorList>
<dbReference type="PubMed" id="17047063"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-05-3096"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH NANOS1</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-675</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="38">
<citation type="journal article" date="2006" name="EMBO J." volume="25" first="3275" last="3285">
<title>The inner nuclear membrane protein emerin regulates beta-catenin activity by restricting its accumulation in the nucleus.</title>
<authorList>
<person name="Markiewicz E."/>
<person name="Tilgner K."/>
<person name="Barker N."/>
<person name="van de Wetering M."/>
<person name="Clevers H."/>
<person name="Dorobek M."/>
<person name="Hausmanowa-Petrusewicz I."/>
<person name="Ramaekers F.C.S."/>
<person name="Broers J.L.V."/>
<person name="Blankesteijn W.M."/>
<person name="Salpingidou G."/>
<person name="Wilson R.G."/>
<person name="Ellis J.A."/>
<person name="Hutchison C.J."/>
</authorList>
<dbReference type="PubMed" id="16858403"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7601230"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH EMD</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2007" name="Biochim. Biophys. Acta" volume="1773" first="1028" last="1038">
<title>MUC1 inhibits cell proliferation by a beta-catenin-dependent mechanism.</title>
<authorList>
<person name="Lillehoj E.P."/>
<person name="Lu W."/>
<person name="Kiser T."/>
<person name="Goldblum S.E."/>
<person name="Kim K.C."/>
</authorList>
<dbReference type="PubMed" id="17524503"/>
<dbReference type="DOI" id="10.1016/j.bbamcr.2007.04.009"/>
</citation>
<scope>INTERACTION WITH MUC1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2007" name="FEBS Lett." volume="581" first="858" last="864">
<title>The Kruppel-like zinc finger protein Glis2 functions as a negative modulator of the Wnt/beta-catenin signaling pathway.</title>
<authorList>
<person name="Kim Y.-S."/>
<person name="Kang H.S."/>
<person name="Jetten A.M."/>
</authorList>
<dbReference type="PubMed" id="17289029"/>
<dbReference type="DOI" id="10.1016/j.febslet.2007.01.058"/>
</citation>
<scope>INTERACTION WITH GLIS2</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2007" name="J. Cell. Biochem." volume="100" first="738" last="749">
<title>cdk5 modulates beta- and delta-catenin/Pin1 interactions in neuronal cells.</title>
<authorList>
<person name="Munoz J.P."/>
<person name="Huichalaf C.H."/>
<person name="Orellana D."/>
<person name="Maccioni R.B."/>
</authorList>
<dbReference type="PubMed" id="17009320"/>
<dbReference type="DOI" id="10.1002/jcb.21041"/>
</citation>
<scope>PHOSPHORYLATION AT SER-191 AND SER-246</scope>
<scope>INTERACTION WITH CDK5</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="20344" last="20349">
<title>The tumor suppressor Fhit acts as a repressor of beta-catenin transcriptional activity.</title>
<authorList>
<person name="Weiske J."/>
<person name="Albring K.F."/>
<person name="Huber O."/>
</authorList>
<dbReference type="PubMed" id="18077326"/>
<dbReference type="DOI" id="10.1073/pnas.0703664105"/>
</citation>
<scope>INTERACTION WITH FHIT</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH LEF1</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2008" name="Genes Dev." volume="22" first="91" last="105">
<title>beta-Catenin is a Nek2 substrate involved in centrosome separation.</title>
<authorList>
<person name="Bahmanyar S."/>
<person name="Kaplan D.D."/>
<person name="Deluca J.G."/>
<person name="Giddings T.H. Jr."/>
<person name="O'Toole E.T."/>
<person name="Winey M."/>
<person name="Salmon E.D."/>
<person name="Casey P.J."/>
<person name="Nelson W.J."/>
<person name="Barth A.I."/>
</authorList>
<dbReference type="PubMed" id="18086858"/>
<dbReference type="DOI" id="10.1101/gad.1596308"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION</scope>
<scope>INTERACTION WITH NEK2</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-556 AND SER-675</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="45">
<citation type="journal article" date="2008" name="Mol. Cancer Res." volume="6" first="1421" last="1430">
<title>Sox7 Is an independent checkpoint for beta-catenin function in prostate and colon epithelial cells.</title>
<authorList>
<person name="Guo L."/>
<person name="Zhong D."/>
<person name="Lau S."/>
<person name="Liu X."/>
<person name="Dong X.Y."/>
<person name="Sun X."/>
<person name="Yang V.W."/>
<person name="Vertino P.M."/>
<person name="Moreno C.S."/>
<person name="Varma V."/>
<person name="Dong J.T."/>
<person name="Zhou W."/>
</authorList>
<dbReference type="PubMed" id="18819930"/>
<dbReference type="DOI" id="10.1158/1541-7786.mcr-07-2175"/>
</citation>
<scope>INTERACTION WITH SOX7</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2008" name="Mol. Cell. Biol." volume="28" first="3894" last="3904">
<title>CHD8 is an ATP-dependent chromatin remodeling factor that regulates beta-catenin target genes.</title>
<authorList>
<person name="Thompson B.A."/>
<person name="Tremblay V."/>
<person name="Lin G."/>
<person name="Bochar D.A."/>
</authorList>
<dbReference type="PubMed" id="18378692"/>
<dbReference type="DOI" id="10.1128/mcb.00322-08"/>
</citation>
<scope>INTERACTION WITH CHD8</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="48">
<citation type="journal article" date="2009" name="EMBO J." volume="28" first="3329" last="3340">
<title>The kinase TNIK is an essential activator of Wnt target genes.</title>
<authorList>
<person name="Mahmoudi T."/>
<person name="Li V.S.W."/>
<person name="Ng S.S."/>
<person name="Taouatas N."/>
<person name="Vries R.G.J."/>
<person name="Mohammed S."/>
<person name="Heck A.J."/>
<person name="Clevers H."/>
</authorList>
<dbReference type="PubMed" id="19816403"/>
<dbReference type="DOI" id="10.1038/emboj.2009.285"/>
</citation>
<scope>INTERACTION WITH TCF7L2 AND TNIK</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="2012" last="2022">
<title>Down-regulation of death-associated protein kinase-2 is required for beta-catenin-induced anoikis resistance of malignant epithelial cells.</title>
<authorList>
<person name="Li H."/>
<person name="Ray G."/>
<person name="Yoo B.H."/>
<person name="Erdogan M."/>
<person name="Rosen K.V."/>
</authorList>
<dbReference type="PubMed" id="18957423"/>
<dbReference type="DOI" id="10.1074/jbc.m805612200"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="18115" last="18128">
<title>Endosomal adaptor proteins APPL1 and APPL2 are novel activators of beta-catenin/TCF-mediated transcription.</title>
<authorList>
<person name="Rashid S."/>
<person name="Pilecka I."/>
<person name="Torun A."/>
<person name="Olchowik M."/>
<person name="Bielinska B."/>
<person name="Miaczynska M."/>
</authorList>
<dbReference type="PubMed" id="19433865"/>
<dbReference type="DOI" id="10.1074/jbc.m109.007237"/>
</citation>
<scope>INTERACTION WITH RUVBL2; APPL2; APPL1; HDAC1 AND HDAC2</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="52">
<citation type="journal article" date="2010" name="Biochem. Biophys. Res. Commun." volume="394" first="966" last="971">
<title>Homeodomain-interacting protein kinase 2 (HIPK2) targets beta-catenin for phosphorylation and proteasomal degradation.</title>
<authorList>
<person name="Kim E.-A."/>
<person name="Kim J.E."/>
<person name="Sung K.S."/>
<person name="Choi D.W."/>
<person name="Lee B.J."/>
<person name="Choi C.Y."/>
</authorList>
<dbReference type="PubMed" id="20307497"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2010.03.099"/>
</citation>
<scope>PHOSPHORYLATION AT SER-33 AND SER-37 BY HIPK2</scope>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="12426" last="12434">
<title>The phospholipid-binding protein SESTD1 is a novel regulator of the transient receptor potential channels TRPC4 and TRPC5.</title>
<authorList>
<person name="Miehe S."/>
<person name="Bieberstein A."/>
<person name="Arnould I."/>
<person name="Ihdene O."/>
<person name="Rutten H."/>
<person name="Strubing C."/>
</authorList>
<dbReference type="PubMed" id="20164195"/>
<dbReference type="DOI" id="10.1074/jbc.m109.068304"/>
</citation>
<scope>INTERACTION WITH SESTD1</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="4213" last="4223">
<title>Cell-cell contact formation governs Ca2+ signaling by TRPC4 in the vascular endothelium: evidence for a regulatory TRPC4-beta-catenin interaction.</title>
<authorList>
<person name="Graziani A."/>
<person name="Poteser M."/>
<person name="Heupel W.M."/>
<person name="Schleifer H."/>
<person name="Krenn M."/>
<person name="Drenckhahn D."/>
<person name="Romanin C."/>
<person name="Baumgartner W."/>
<person name="Groschner K."/>
</authorList>
<dbReference type="PubMed" id="19996314"/>
<dbReference type="DOI" id="10.1074/jbc.m109.060301"/>
</citation>
<scope>INTERACTION WITH TRPC4</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2010" name="Mol. Biol. Rep." volume="37" first="2415" last="2421">
<title>Characterization of a novel human CDK5 splicing variant that inhibits Wnt/beta-catenin signaling.</title>
<authorList>
<person name="Li Q."/>
<person name="Liu X."/>
<person name="Zhang M."/>
<person name="Ye G."/>
<person name="Qiao Q."/>
<person name="Ling Y."/>
<person name="Wu Y."/>
<person name="Zhang Y."/>
<person name="Yu L."/>
</authorList>
<dbReference type="PubMed" id="19693690"/>
<dbReference type="DOI" id="10.1007/s11033-009-9752-7"/>
</citation>
<scope>INTERACTION WITH CDK5</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2010" name="J. Cell Sci." volume="123" first="236" last="245">
<title>Identification of beta-catenin as a target of the intracellular tyrosine kinase PTK6.</title>
<authorList>
<person name="Palka-Hamblin H.L."/>
<person name="Gierut J.J."/>
<person name="Bie W."/>
<person name="Brauer P.M."/>
<person name="Zheng Y."/>
<person name="Asara J.M."/>
<person name="Tyner A.L."/>
</authorList>
<dbReference type="PubMed" id="20026641"/>
<dbReference type="DOI" id="10.1242/jcs.053264"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-64; TYR-142; TYR-331 AND TYR-333</scope>
<scope>INTERACTION WITH PTK6</scope>
<scope>MUTAGENESIS OF TYR-64</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-675</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="58">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2011" name="Cell. Signal." volume="23" first="911" last="919">
<title>Compartmentalized CDK2 is connected with SHP-1 and beta-catenin and regulates insulin internalization.</title>
<authorList>
<person name="Fiset A."/>
<person name="Xu E."/>
<person name="Bergeron S."/>
<person name="Marette A."/>
<person name="Pelletier G."/>
<person name="Siminovitch K.A."/>
<person name="Olivier M."/>
<person name="Beauchemin N."/>
<person name="Faure R.L."/>
</authorList>
<dbReference type="PubMed" id="21262353"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2011.01.019"/>
</citation>
<scope>FUNCTION IN INSULIN INTERNALIZATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH CDK2</scope>
<scope>PHOSPHORYLATION BY CDK2</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2011" name="EMBO Rep." volume="12" first="43" last="49">
<title>Protein tyrosine kinase 7 has a conserved role in Wnt/beta-catenin canonical signalling.</title>
<authorList>
<person name="Puppo F."/>
<person name="Thome V."/>
<person name="Lhoumeau A.-C."/>
<person name="Cibois M."/>
<person name="Gangar A."/>
<person name="Lembo F."/>
<person name="Belotti E."/>
<person name="Marchetto S."/>
<person name="Lecine P."/>
<person name="Prebet T."/>
<person name="Sebbagh M."/>
<person name="Shin W.-S."/>
<person name="Lee S.-T."/>
<person name="Kodjabachian L."/>
<person name="Borg J.-P."/>
</authorList>
<dbReference type="PubMed" id="21132015"/>
<dbReference type="DOI" id="10.1038/embor.2010.185"/>
</citation>
<scope>INTERACTION WITH PKT7</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="12450" last="12460">
<title>Crystal structure of the human N-Myc downstream-regulated gene 2 protein provides insight into its role as a tumor suppressor.</title>
<authorList>
<person name="Hwang J."/>
<person name="Kim Y."/>
<person name="Kang H.B."/>
<person name="Jaroszewski L."/>
<person name="Deacon A.M."/>
<person name="Lee H."/>
<person name="Choi W.C."/>
<person name="Kim K.J."/>
<person name="Kim C.H."/>
<person name="Kang B.S."/>
<person name="Lee J.O."/>
<person name="Oh T.K."/>
<person name="Kim J.W."/>
<person name="Wilson I.A."/>
<person name="Kim M.H."/>
</authorList>
<dbReference type="PubMed" id="21247902"/>
<dbReference type="DOI" id="10.1074/jbc.m110.170803"/>
</citation>
<scope>INTERACTION WITH NDRG2</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2011" name="Nat. Med." volume="17" first="726" last="731">
<title>Defective Wnt-dependent cerebellar midline fusion in a mouse model of Joubert syndrome.</title>
<authorList>
<person name="Lancaster M.A."/>
<person name="Gopal D.J."/>
<person name="Kim J."/>
<person name="Saleem S.N."/>
<person name="Silhavy J.L."/>
<person name="Louie C.M."/>
<person name="Thacker B.E."/>
<person name="Williams Y."/>
<person name="Zaki M.S."/>
<person name="Gleeson J.G."/>
</authorList>
<dbReference type="PubMed" id="21623382"/>
<dbReference type="DOI" id="10.1038/nm.2380"/>
</citation>
<scope>INTERACTION WITH AHI1</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-191 AND SER-552</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2012" name="Cell Cycle" volume="11" first="2206" last="2215">
<title>The tumor suppressor HINT1 regulates MITF and beta-catenin transcriptional activity in melanoma cells.</title>
<authorList>
<person name="Genovese G."/>
<person name="Ghosh P."/>
<person name="Li H."/>
<person name="Rettino A."/>
<person name="Sioletic S."/>
<person name="Cittadini A."/>
<person name="Sgambato A."/>
</authorList>
<dbReference type="PubMed" id="22647378"/>
<dbReference type="DOI" id="10.4161/cc.20765"/>
</citation>
<scope>IDENTIFICATION IN A COMPLEX WITH HINT1 AND MITF</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2012" name="EMBO Rep." volume="13" first="750" last="758">
<title>Kindlin 2 forms a transcriptional complex with beta-catenin and TCF4 to enhance Wnt signalling.</title>
<authorList>
<person name="Yu Y."/>
<person name="Wu J."/>
<person name="Wang Y."/>
<person name="Zhao T."/>
<person name="Ma B."/>
<person name="Liu Y."/>
<person name="Fang W."/>
<person name="Zhu W.G."/>
<person name="Zhang H."/>
</authorList>
<dbReference type="PubMed" id="22699938"/>
<dbReference type="DOI" id="10.1038/embor.2012.88"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH FERMT2</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH FERMT2 AND TCF7L2</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2012" name="Gastroenterology" volume="142" first="572" last="581">
<title>Beta-catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells.</title>
<authorList>
<person name="Satow R."/>
<person name="Shitashige M."/>
<person name="Jigami T."/>
<person name="Fukami K."/>
<person name="Honda K."/>
<person name="Kitabayashi I."/>
<person name="Yamada T."/>
</authorList>
<dbReference type="PubMed" id="22155184"/>
<dbReference type="DOI" id="10.1053/j.gastro.2011.11.041"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PML</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2012" name="N. Engl. J. Med." volume="367" first="1921" last="1929">
<title>Diagnostic exome sequencing in persons with severe intellectual disability.</title>
<authorList>
<person name="de Ligt J."/>
<person name="Willemsen M.H."/>
<person name="van Bon B.W."/>
<person name="Kleefstra T."/>
<person name="Yntema H.G."/>
<person name="Kroes T."/>
<person name="Vulto-van Silfhout A.T."/>
<person name="Koolen D.A."/>
<person name="de Vries P."/>
<person name="Gilissen C."/>
<person name="del Rosario M."/>
<person name="Hoischen A."/>
<person name="Scheffer H."/>
<person name="de Vries B.B."/>
<person name="Brunner H.G."/>
<person name="Veltman J.A."/>
<person name="Vissers L.E."/>
</authorList>
<dbReference type="PubMed" id="23033978"/>
<dbReference type="DOI" id="10.1056/nejmoa1206524"/>
</citation>
<scope>INVOLVEMENT IN NEDSDV</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2014" name="Development" volume="141" first="3529" last="3539">
<title>Simplet/Fam53b is required for Wnt signal transduction by regulating beta-catenin nuclear localization.</title>
<authorList>
<person name="Kizil C."/>
<person name="Kuechler B."/>
<person name="Yan J.J."/>
<person name="Oezhan G."/>
<person name="Moro E."/>
<person name="Argenton F."/>
<person name="Brand M."/>
<person name="Weidinger G."/>
<person name="Antos C.L."/>
</authorList>
<dbReference type="PubMed" id="25183871"/>
<dbReference type="DOI" id="10.1242/dev.108415"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH FAM53B</scope>
</reference>
<reference key="70">
<citation type="journal article" date="2014" name="Exp. Cell Res." volume="321" first="153" last="166">
<title>beta-catenin is O-GlcNAc glycosylated at Serine 23: implications for beta-catenin's subcellular localization and transactivator function.</title>
<authorList>
<person name="Ha J.R."/>
<person name="Hao L."/>
<person name="Venkateswaran G."/>
<person name="Huang Y.H."/>
<person name="Garcia E."/>
<person name="Persad S."/>
</authorList>
<dbReference type="PubMed" id="24342833"/>
<dbReference type="DOI" id="10.1016/j.yexcr.2013.11.021"/>
</citation>
<scope>GLYCOSYLATION AT SER-23</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="71">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-191 AND SER-552</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="72">
<citation type="journal article" date="2014" name="Mol. Cell. Biol." volume="34" first="4355" last="4366">
<title>The ubiquitin ligase RNF220 enhances canonical Wnt signaling through USP7-mediated deubiquitination of beta-catenin.</title>
<authorList>
<person name="Ma P."/>
<person name="Yang X."/>
<person name="Kong Q."/>
<person name="Li C."/>
<person name="Yang S."/>
<person name="Li Y."/>
<person name="Mao B."/>
</authorList>
<dbReference type="PubMed" id="25266658"/>
<dbReference type="DOI" id="10.1128/mcb.00731-14"/>
</citation>
<scope>INTERACTION WITH RNF220</scope>
</reference>
<reference key="73">
<citation type="journal article" date="2015" name="Int. J. Cancer" volume="136" first="55" last="64">
<title>MCC inhibits beta-catenin transcriptional activity by sequestering DBC1 in the cytoplasm.</title>
<authorList>
<person name="Pangon L."/>
<person name="Mladenova D."/>
<person name="Watkins L."/>
<person name="Van Kralingen C."/>
<person name="Currey N."/>
<person name="Al-Sohaily S."/>
<person name="Lecine P."/>
<person name="Borg J.P."/>
<person name="Kohonen-Corish M.R."/>
</authorList>
<dbReference type="PubMed" id="24824780"/>
<dbReference type="DOI" id="10.1002/ijc.28967"/>
</citation>
<scope>ACETYLATION AT LYS-49</scope>
<scope>DEACETYLATION</scope>
</reference>
<reference key="74">
<citation type="journal article" date="2015" name="J. Cell. Biochem." volume="116" first="170" last="178">
<title>HN1 negatively influences the beta-catenin/E-cadherin interaction, and contributes to migration in prostate cells.</title>
<authorList>
<person name="Varisli L."/>
<person name="Ozturk B.E."/>
<person name="Akyuz G.K."/>
<person name="Korkmaz K.S."/>
</authorList>
<dbReference type="PubMed" id="25169422"/>
<dbReference type="DOI" id="10.1002/jcb.24956"/>
</citation>
<scope>INTERACTION WITH JPT1</scope>
<scope>PHOSPHORYLATION AT SER-33</scope>
</reference>
<reference key="75">
<citation type="journal article" date="2015" name="Nature" volume="520" first="51" last="56">
<title>Loss of delta-catenin function in severe autism.</title>
<authorList>
<person name="Turner T.N."/>
<person name="Sharma K."/>
<person name="Oh E.C."/>
<person name="Liu Y.P."/>
<person name="Collins R.L."/>
<person name="Sosa M.X."/>
<person name="Auer D.R."/>
<person name="Brand H."/>
<person name="Sanders S.J."/>
<person name="Moreno-De-Luca D."/>
<person name="Pihur V."/>
<person name="Plona T."/>
<person name="Pike K."/>
<person name="Soppet D.R."/>
<person name="Smith M.W."/>
<person name="Cheung S.W."/>
<person name="Martin C.L."/>
<person name="State M.W."/>
<person name="Talkowski M.E."/>
<person name="Cook E."/>
<person name="Huganir R."/>
<person name="Katsanis N."/>
<person name="Chakravarti A."/>
</authorList>
<dbReference type="PubMed" id="25807484"/>
<dbReference type="DOI" id="10.1038/nature14186"/>
</citation>
<scope>INTERACTION WITH CTNND2</scope>
</reference>
<reference key="76">
<citation type="journal article" date="2017" name="Cell Res." volume="27" first="1422" last="1440">
<title>Twa1/Gid8 is a beta-catenin nuclear retention factor in Wnt signaling and colorectal tumorigenesis.</title>
<authorList>
<person name="Lu Y."/>
<person name="Xie S."/>
<person name="Zhang W."/>
<person name="Zhang C."/>
<person name="Gao C."/>
<person name="Sun Q."/>
<person name="Cai Y."/>
<person name="Xu Z."/>
<person name="Xiao M."/>
<person name="Xu Y."/>
<person name="Huang X."/>
<person name="Wu X."/>
<person name="Liu W."/>
<person name="Wang F."/>
<person name="Kang Y."/>
<person name="Zhou T."/>
</authorList>
<dbReference type="PubMed" id="28829046"/>
<dbReference type="DOI" id="10.1038/cr.2017.107"/>
</citation>
<scope>INTERACTION WITH GID8; AXIN1 AND TCF7L2</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="77">
<citation type="journal article" date="2017" name="Mucosal Immunol." volume="10" first="1190" last="1201">
<title>Cadherin 26 is an alpha integrin-binding epithelial receptor regulated during allergic inflammation.</title>
<authorList>
<person name="Caldwell J.M."/>
<person name="Collins M.H."/>
<person name="Kemme K.A."/>
<person name="Sherrill J.D."/>
<person name="Wen T."/>
<person name="Rochman M."/>
<person name="Stucke E.M."/>
<person name="Amin L."/>
<person name="Tai H."/>
<person name="Putnam P.E."/>
<person name="Jimenez-Dalmaroni M.J."/>
<person name="Wormald M.R."/>
<person name="Porollo A."/>
<person name="Abonia J.P."/>
<person name="Rothenberg M.E."/>
</authorList>
<dbReference type="PubMed" id="28051089"/>
<dbReference type="DOI" id="10.1038/mi.2016.120"/>
</citation>
<scope>IDENTIFICATION IN A CADHERIN/CATENIN ADHESION COMPLEX</scope>
</reference>
<reference key="78">
<citation type="journal article" date="2018" name="Biochem. Biophys. Res. Commun." volume="497" first="381" last="387">
<title>KSHV vPK inhibits Wnt signaling via preventing interactions between beta-catenin and TCF4.</title>
<authorList>
<person name="Cha S."/>
<person name="Kang M.S."/>
<person name="Seo T."/>
</authorList>
<dbReference type="PubMed" id="29432739"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2018.02.089"/>
</citation>
<scope>INTERACTION WITH TCF7L2/TCF4 AND HERPES VIRUS 8 PROTEIN VPK (MICROBIAL INFECTION)</scope>
</reference>
<reference key="79">
<citation type="journal article" date="2018" name="Cell Death Dis." volume="9" first="91" last="91">
<title>Transmembrane protein 170B is a novel breast tumorigenesis suppressor gene that inhibits the Wnt/beta-catenin pathway.</title>
<authorList>
<person name="Li M."/>
<person name="Han Y."/>
<person name="Zhou H."/>
<person name="Li X."/>
<person name="Lin C."/>
<person name="Zhang E."/>
<person name="Chi X."/>
<person name="Hu J."/>
<person name="Xu H."/>
</authorList>
<dbReference type="PubMed" id="29367600"/>
<dbReference type="DOI" id="10.1038/s41419-017-0128-y"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH TMEM170B</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="80">
<citation type="journal article" date="2017" name="Am. J. Hum. Genet." volume="100" first="960" last="968">
<title>Defects in the cell signaling mediator beta-catenin cause the retinal vascular condition FEVR.</title>
<authorList>
<person name="Panagiotou E.S."/>
<person name="Sanjurjo Soriano C."/>
<person name="Poulter J.A."/>
<person name="Lord E.C."/>
<person name="Dzulova D."/>
<person name="Kondo H."/>
<person name="Hiyoshi A."/>
<person name="Chung B.H."/>
<person name="Chu Y.W."/>
<person name="Lai C.H.Y."/>
<person name="Tafoya M.E."/>
<person name="Karjosukarso D."/>
<person name="Collin R.W.J."/>
<person name="Topping J."/>
<person name="Downey L.M."/>
<person name="Ali M."/>
<person name="Inglehearn C.F."/>
<person name="Toomes C."/>
</authorList>
<dbReference type="PubMed" id="28575650"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2017.05.001"/>
</citation>
<scope>INVOLVEMENT IN EVR7</scope>
<scope>VARIANT EVR7 CYS-710</scope>
</reference>
<reference key="81">
<citation type="journal article" date="2018" name="Cancer Res." volume="78" first="1643" last="1656">
<title>Forkhead Box F2 Suppresses Gastric Cancer through a Novel FOXF2-IRF2BPL-beta-Catenin Signaling Axis.</title>
<authorList>
<person name="Higashimori A."/>
<person name="Dong Y."/>
<person name="Zhang Y."/>
<person name="Kang W."/>
<person name="Nakatsu G."/>
<person name="Ng S.S.M."/>
<person name="Arakawa T."/>
<person name="Sung J.J.Y."/>
<person name="Chan F.K.L."/>
<person name="Yu J."/>
</authorList>
<dbReference type="PubMed" id="29374064"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-17-2403"/>
</citation>
<scope>INTERACTION WITH IRF2BPL</scope>
<scope>VARIANT TYR-33</scope>
</reference>
<reference key="82">
<citation type="journal article" date="2018" name="EBioMedicine" volume="31" first="253" last="266">
<title>SOX30 Inhibits Tumor Metastasis through Attenuating Wnt-Signaling via Transcriptional and Posttranslational Regulation of beta-Catenin in Lung Cancer.</title>
<authorList>
<person name="Han F."/>
<person name="Liu W.B."/>
<person name="Shi X.Y."/>
<person name="Yang J.T."/>
<person name="Zhang X."/>
<person name="Li Z.M."/>
<person name="Jiang X."/>
<person name="Yin L."/>
<person name="Li J.J."/>
<person name="Huang C.S."/>
<person name="Cao J."/>
<person name="Liu J.Y."/>
</authorList>
<dbReference type="PubMed" id="29739711"/>
<dbReference type="DOI" id="10.1016/j.ebiom.2018.04.026"/>
</citation>
<scope>INTERACTION WITH SOX30 AND TCF7L2</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="83">
<citation type="journal article" date="2019" name="Science" volume="364">
<title>LMBR1L regulates lymphopoiesis through Wnt/beta-catenin signaling.</title>
<authorList>
<person name="Choi J.H."/>
<person name="Zhong X."/>
<person name="McAlpine W."/>
<person name="Liao T.C."/>
<person name="Zhang D."/>
<person name="Fang B."/>
<person name="Russell J."/>
<person name="Ludwig S."/>
<person name="Nair-Gill E."/>
<person name="Zhang Z."/>
<person name="Wang K.W."/>
<person name="Misawa T."/>
<person name="Zhan X."/>
<person name="Choi M."/>
<person name="Wang T."/>
<person name="Li X."/>
<person name="Tang M."/>
<person name="Sun Q."/>
<person name="Yu L."/>
<person name="Murray A.R."/>
<person name="Moresco E.M.Y."/>
<person name="Beutler B."/>
</authorList>
<dbReference type="PubMed" id="31073040"/>
<dbReference type="DOI" id="10.1126/science.aau0812"/>
</citation>
<scope>INTERACTION WITH LMBR1L</scope>
</reference>
<reference key="84">
<citation type="journal article" date="2000" name="Cell" volume="103" first="885" last="896">
<title>Crystal structure of a beta-catenin/Tcf complex.</title>
<authorList>
<person name="Graham T.A."/>
<person name="Weaver C."/>
<person name="Mao F."/>
<person name="Kimelman D."/>
<person name="Xu W."/>
</authorList>
<dbReference type="PubMed" id="11136974"/>
<dbReference type="DOI" id="10.1016/s0092-8674(00)00192-6"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 133-664</scope>
</reference>
<reference key="85">
<citation type="journal article" date="2001" name="Nat. Struct. Biol." volume="8" first="1048" last="1052">
<title>Tcf4 can specifically recognize beta-catenin using alternative conformations.</title>
<authorList>
<person name="Graham T.A."/>
<person name="Ferkey D.M."/>
<person name="Mao F."/>
<person name="Kimelman D."/>
<person name="Xu W."/>
</authorList>
<dbReference type="PubMed" id="11713475"/>
<dbReference type="DOI" id="10.1038/nsb718"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 134-664 IN COMPLEX WITH TCF7L2</scope>
<scope>MUTAGENESIS OF LYS-312 AND LYS-435</scope>
</reference>
<reference key="86">
<citation type="journal article" date="2001" name="Nat. Struct. Biol." volume="8" first="1053" last="1057">
<title>Structure of a human Tcf4-beta-catenin complex.</title>
<authorList>
<person name="Poy F."/>
<person name="Lepourcelet M."/>
<person name="Shivdasani R.A."/>
<person name="Eck M.J."/>
</authorList>
<dbReference type="PubMed" id="11713476"/>
<dbReference type="DOI" id="10.1038/nsb720"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 134-668 IN COMPLEX WITH TCF7L2</scope>
</reference>
<reference key="87">
<citation type="journal article" date="2002" name="Mol. Cell" volume="10" first="563" last="571">
<title>The crystal structure of the beta-catenin/ICAT complex reveals the inhibitory mechanism of ICAT.</title>
<authorList>
<person name="Graham T.A."/>
<person name="Clements W.K."/>
<person name="Kimelman D."/>
<person name="Xu W."/>
</authorList>
<dbReference type="PubMed" id="12408824"/>
<dbReference type="DOI" id="10.1016/s1097-2765(02)00637-8"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 134-664 IN COMPLEX WITH CTNNBIP1</scope>
<scope>MUTAGENESIS OF PHE-660 AND ARG-661</scope>
</reference>
<reference key="88">
<citation type="journal article" date="2006" name="Mol. Cell" volume="24" first="293" last="300">
<title>Crystal structure of a beta-catenin/BCL9/Tcf4 complex.</title>
<authorList>
<person name="Sampietro J."/>
<person name="Dahlberg C.L."/>
<person name="Cho U.S."/>
<person name="Hinds T.R."/>
<person name="Kimelman D."/>
<person name="Xu W."/>
</authorList>
<dbReference type="PubMed" id="17052462"/>
<dbReference type="DOI" id="10.1016/j.molcel.2006.09.001"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 1-136 IN COMPLEX WITH BCL9 AND TCF7L2</scope>
<scope>INTERACTION WITH BCL9; BCL9L CDH3 AND TCF7L2</scope>
<scope>MUTAGENESIS OF TYR-142; LEU-156; LEU-159 AND LEU-178</scope>
</reference>
<reference key="89">
<citation type="journal article" date="1997" name="Science" volume="275" first="1787" last="1790">
<title>Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.</title>
<authorList>
<person name="Morin P.J."/>
<person name="Sparks A.B."/>
<person name="Korinek V."/>
<person name="Barker N."/>
<person name="Clevers H."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
</authorList>
<dbReference type="PubMed" id="9065402"/>
<dbReference type="DOI" id="10.1126/science.275.5307.1787"/>
</citation>
<scope>VARIANTS COLORECTAL CANCER TYR-33 AND SER-45 DEL</scope>
</reference>
<reference key="90">
<citation type="journal article" date="1999" name="Cancer Res." volume="59" first="269" last="273">
<title>Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene.</title>
<authorList>
<person name="Koch A."/>
<person name="Denkhaus D."/>
<person name="Albrecht S."/>
<person name="Leuschner I."/>
<person name="von Schweinitz D."/>
<person name="Pietsch T."/>
</authorList>
<dbReference type="PubMed" id="9927029"/>
</citation>
<scope>VARIANTS HEPATOBLASTOMA TYR-32; VAL-34; CYS-37 AND ALA-41</scope>
</reference>
<reference key="91">
<citation type="journal article" date="1999" name="Genes Chromosomes Cancer" volume="25" first="399" last="402">
<title>Beta-catenin accumulation and mutation of the CTNNB1 gene in hepatoblastoma.</title>
<authorList>
<person name="Blaeker H."/>
<person name="Hofmann W.J."/>
<person name="Rieker R.J."/>
<person name="Penzel R."/>
<person name="Graf M."/>
<person name="Otto H.F."/>
</authorList>
<dbReference type="PubMed" id="10398436"/>
<dbReference type="DOI" id="10.1002/(sici)1098-2264(199908)25:4&lt;399::aid-gcc14&gt;3.0.co;2-x"/>
</citation>
<scope>VARIANT HEPATOBLASTOMA ALA-41</scope>
</reference>
<reference key="92">
<citation type="journal article" date="1999" name="Jpn. J. Cancer Res." volume="90" first="510" last="515">
<title>Mutational analysis of beta-catenin gene in Japanese ovarian carcinomas: frequent mutations in endometrioid carcinomas.</title>
<authorList>
<person name="Sagae S."/>
<person name="Kobayashi K."/>
<person name="Nishioka Y."/>
<person name="Sugimura M."/>
<person name="Ishioka S."/>
<person name="Nagata M."/>
<person name="Terasawa K."/>
<person name="Tokino T."/>
<person name="Kudo R."/>
</authorList>
<dbReference type="PubMed" id="10391090"/>
<dbReference type="DOI" id="10.1111/j.1349-7006.1999.tb00777.x"/>
</citation>
<scope>VARIANTS OVARIAN CANCER CYS-37; ILE-41 AND ALA-41</scope>
</reference>
<reference key="93">
<citation type="journal article" date="1999" name="J. Clin. Pathol." volume="52" first="695" last="696">
<title>A novel case of a sporadic desmoid tumour with mutation of the beta catenin gene.</title>
<authorList>
<person name="Shitoh K."/>
<person name="Konishi F."/>
<person name="Iijima T."/>
<person name="Ohdaira T."/>
<person name="Sakai K."/>
<person name="Kanazawa K."/>
<person name="Miyaki M."/>
</authorList>
<dbReference type="PubMed" id="10655994"/>
<dbReference type="DOI" id="10.1136/jcp.52.9.695"/>
</citation>
<scope>VARIANT DESMOID TUMOR ALA-41</scope>
</reference>
<reference key="94">
<citation type="journal article" date="1999" name="Nat. Genet." volume="21" first="410" last="413">
<title>A common human skin tumour is caused by activating mutations in beta-catenin.</title>
<authorList>
<person name="Chan E.F."/>
<person name="Gat U."/>
<person name="McNiff J.M."/>
<person name="Fuchs E."/>
</authorList>
<dbReference type="PubMed" id="10192393"/>
<dbReference type="DOI" id="10.1038/7747"/>
</citation>
<scope>VARIANTS PTR GLY-32; TYR-32; PHE-33; TYR-33; GLU-34; CYS-37; PHE-37 AND ILE-41</scope>
</reference>
<reference key="95">
<citation type="journal article" date="1999" name="Oncogene" volume="18" first="4044" last="4046">
<title>Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity.</title>
<authorList>
<person name="Legoix P."/>
<person name="Bluteau O."/>
<person name="Bayer J."/>
<person name="Perret C."/>
<person name="Balabaud C."/>
<person name="Belghiti J."/>
<person name="Franco D."/>
<person name="Thomas G."/>
<person name="Laurent-Puig P."/>
<person name="Zucman-Rossi J."/>
</authorList>
<dbReference type="PubMed" id="10435629"/>
<dbReference type="DOI" id="10.1038/sj.onc.1202800"/>
</citation>
<scope>VARIANTS HEPATOCELLULAR CARCINOMA ARG-23; 25-TRP--SER-33 DEL; ALA-32; GLY-32; TYR-32; LEU-33; PHE-33; ARG-34; SER-35; ALA-37; 37-SER-GLY-38 DELINS TRP; TYR-37; ALA-41; ILE-41; PHE-45 AND PRO-45</scope>
</reference>
<reference key="96">
<citation type="journal article" date="2000" name="Am. J. Pathol." volume="156" first="433" last="437">
<title>APC mutations in sporadic medulloblastomas.</title>
<authorList>
<person name="Huang H."/>
<person name="Mahler-Araujo B.M."/>
<person name="Sankila A."/>
<person name="Chimelli L."/>
<person name="Yonekawa Y."/>
<person name="Kleihues P."/>
<person name="Ohgaki H."/>
</authorList>
<dbReference type="PubMed" id="10666372"/>
<dbReference type="DOI" id="10.1016/s0002-9440(10)64747-5"/>
</citation>
<scope>VARIANTS MDB PHE-33 AND ALA-37</scope>
</reference>
<reference key="97">
<citation type="journal article" date="2015" name="Hum. Genet." volume="134" first="97" last="109">
<title>De novo mutations in beta-catenin (CTNNB1) appear to be a frequent cause of intellectual disability: expanding the mutational and clinical spectrum.</title>
<authorList>
<person name="Kuechler A."/>
<person name="Willemsen M.H."/>
<person name="Albrecht B."/>
<person name="Bacino C.A."/>
<person name="Bartholomew D.W."/>
<person name="van Bokhoven H."/>
<person name="van den Boogaard M.J."/>
<person name="Bramswig N."/>
<person name="Buettner C."/>
<person name="Cremer K."/>
<person name="Czeschik J.C."/>
<person name="Engels H."/>
<person name="van Gassen K."/>
<person name="Graf E."/>
<person name="van Haelst M."/>
<person name="He W."/>
<person name="Hogue J.S."/>
<person name="Kempers M."/>
<person name="Koolen D."/>
<person name="Monroe G."/>
<person name="de Munnik S."/>
<person name="Pastore M."/>
<person name="Reis A."/>
<person name="Reuter M.S."/>
<person name="Tegay D.H."/>
<person name="Veltman J."/>
<person name="Visser G."/>
<person name="van Hasselt P."/>
<person name="Smeets E.E."/>
<person name="Vissers L."/>
<person name="Wieland T."/>
<person name="Wissink W."/>
<person name="Yntema H."/>
<person name="Zink A.M."/>
<person name="Strom T.M."/>
<person name="Luedecke H.J."/>
<person name="Kleefstra T."/>
<person name="Wieczorek D."/>
</authorList>
<dbReference type="PubMed" id="25326669"/>
<dbReference type="DOI" id="10.1007/s00439-014-1498-1"/>
</citation>
<scope>VARIANT NEDSDV PRO-388</scope>
</reference>
<reference key="98">
<citation type="journal article" date="2017" name="Medicine (Baltimore)" volume="96" first="E6914" last="E6914">
<title>Exome sequencing identifies a de novo mutation of CTNNB1 gene in a patient mainly presented with retinal detachment, lens and vitreous opacities, microcephaly, and developmental delay: Case report and literature review.</title>
<authorList>
<person name="Li N."/>
<person name="Xu Y."/>
<person name="Li G."/>
<person name="Yu T."/>
<person name="Yao R.E."/>
<person name="Wang X."/>
<person name="Wang J."/>
</authorList>
<dbReference type="PubMed" id="28514307"/>
<dbReference type="DOI" id="10.1097/md.0000000000006914"/>
</citation>
<scope>VARIANT NEDSDV 558-GLN--LEU-781 DEL</scope>
</reference>
<comment type="function">
<text evidence="16 51 52 53 56 66 68 69 70">Key downstream component of the canonical Wnt signaling pathway (PubMed:17524503, PubMed:18077326, PubMed:18086858, PubMed:18957423, PubMed:21262353, PubMed:22155184, PubMed:22647378, PubMed:22699938). In the absence of Wnt, forms a complex with AXIN1, AXIN2, APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its subsequent degradation by the proteasome (PubMed:17524503, PubMed:18077326, PubMed:18086858, PubMed:18957423, PubMed:21262353, PubMed:22155184, PubMed:22647378, PubMed:22699938). In the presence of Wnt ligand, CTNNB1 is not ubiquitinated and accumulates in the nucleus, where it acts as a coactivator for transcription factors of the TCF/LEF family, leading to activate Wnt responsive genes (PubMed:17524503, PubMed:18077326, PubMed:18086858, PubMed:18957423, PubMed:21262353, PubMed:22155184, PubMed:22647378, PubMed:22699938). Involved in the regulation of cell adhesion, as component of an E-cadherin:catenin adhesion complex (By similarity). Acts as a negative regulator of centrosome cohesion (PubMed:18086858). Involved in the CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalization (PubMed:21262353). Blocks anoikis of malignant kidney and intestinal epithelial cells and promotes their anchorage-independent growth by down-regulating DAPK2 (PubMed:18957423). Disrupts PML function and PML-NB formation by inhibiting RANBP2-mediated sumoylation of PML (PubMed:22155184). Promotes neurogenesis by maintaining sympathetic neuroblasts within the cell cycle (By similarity). Involved in chondrocyte differentiation via interaction with SOX9: SOX9-binding competes with the binding sites of TCF/LEF within CTNNB1, thereby inhibiting the Wnt signaling (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="16 23 24 25 26 28 30 31 32 35 36 37 38 39 40 42 43 44 45 46 47 48 49 50 51 52 53 54 55 57 58 59 60 61 62 64 65 66 67 68 69 70 74 75 76 78 79 82 83 84 85 86 87 88 94">Two separate complex-associated pools are found in the cytoplasm. The majority is present as component of an E-cadherin:catenin adhesion complex composed of at least E-cadherin/CDH1 and beta-catenin/CTNNB1, and possibly alpha-catenin/CTNNA1; the complex is located to adherens junctions. The stable association of CTNNA1 is controversial as CTNNA1 was shown not to bind to F-actin when assembled in the complex. Alternatively, the CTNNA1-containing complex may be linked to F-actin by other proteins such as LIMA1. Another cytoplasmic pool is part of a large complex containing AXIN1, AXIN2, APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its subsequent degradation by the proteasome. Wnt-dependent activation of DVL antagonizes the action of GSK3B. When GSK3B activity is inhibited the complex dissociates, CTNNB1 is dephosphorylated and is no longer targeted for destruction. The stabilized protein translocates to the nucleus, where it binds TCF/LEF-1 family members, TBP, BCL9, BCL9L and possibly also RUVBL1 and CHD8. Binds CTNNBIP and EP300. CTNNB1 forms a ternary complex with LEF1 and EP300 that is disrupted by CTNNBIP1 binding. Interacts with TAX1BP3 (via the PDZ domain); this interaction inhibits the transcriptional activity of CTNNB1. Interacts with AJAP1, BAIAP1, CARM1, CTNNA3, CXADR and PCDH11Y. Binds SLC9A3R1. Interacts with GLIS2 and MUC1. Interacts with SLC30A9. Interacts with XIRP1. Interacts directly with AXIN1; the interaction is regulated by CDK2 phosphorylation of AXIN1. Interacts with SCRIB. Interacts with RAPGEF2. Interacts with PTPRU (via the cytoplasmic juxtamembrane domain). Interacts with EMD. Interacts with TNIK and TCF7L2. Interacts with SESTD1 and TRPC4. Interacts with CAV1. Interacts with TRPV4. The TRPV4 and CTNNB1 complex can interact with CDH1. Interacts with VCL. Interacts with PTPRJ. Interacts with PKT7 and CDK2. Interacts with FAT1 (via the cytoplasmic domain). Interacts with NANOS1 and NDRG2. Interacts with isoform 1 of NEK2. Interacts with both isoform 1 and isoform 2 of CDK5. Interacts with PTK6. Interacts with SOX7; this interaction may lead to proteasomal degradation of active CTNNB1 and thus inhibition of Wnt/beta-catenin-stimulated transcription. Identified in a complex with HINT1 and MITF. Interacts with FHIT. The CTNNB1 and TCF7L2/TCF4 complex interacts with PML (isoform PML-4). Interacts with FERMT2. Identified in a complex with TCF7L2/TCF4 and FERMT2 (PubMed:29739711, PubMed:22699938). Interacts with RORA. May interact with P-cadherin/CDH3. Interacts with RNF220 (PubMed:25266658). Interacts with CTNND2 (PubMed:25807484). Interacts (via the C-terminal region) with CBY1 (PubMed:12712206, PubMed:16424001). The complex composed, at least, of APC, CTNNB1 and GSK3B interacts with JPT1; the interaction requires the inactive form of GSK3B (phosphorylated at 'Ser-9') (PubMed:25169422). Interacts with DLG5 (By similarity). Interacts with FAM53B; promoting translocation to the nucleus (PubMed:25183871). Interacts with TMEM170B (PubMed:29367600). Interacts with AHI1 (PubMed:21623382). Interacts with GID8 (PubMed:28829046). Component of an cadherin:catenin adhesion complex composed of at least of CDH26, beta-catenin/CTNNB1, alpha-catenin/CTNNA1 and p120 catenin/CTNND1 (PubMed:28051089). Forms a complex comprising APPL1, RUVBL2, APPL2, HDAC1 and HDAC2 (PubMed:19433865). Interacts with IRF2BPL; mediates the ubiquitination and degradation of CTNNB1 (PubMed:29374064). Interacts with AMFR (By similarity). Interacts with LMBR1L (PubMed:31073040). Interacts with SOX30; prevents interaction of CTNNB1 with TCF7L2/TCF4 and leads to inhibition of Wnt signaling (PubMed:29739711). Interacts with SOX9; inhibiting CTNNB1 activity by competing with the binding sites of TCF/LEF within CTNNB1, thereby inhibiting the Wnt signaling (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="85">(Microbial infection) Interacts with herpes virus 8 protein vPK; this interaction inhibits the Wnt signaling pathway.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-375543">
<id>P00519</id>
<label>ABL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-351526">
<id>O43707</id>
<label>ACTN4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-6169747">
<id>Q5JTC6</id>
<label>AMER1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-727707">
<id>P25054</id>
<label>APC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>19</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-608057">
<id>P10275</id>
<label>AR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-710484">
<id>O15169</id>
<label>AXIN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>44</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-4400025">
<id>Q9Y2T1</id>
<label>AXIN2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-533127">
<id>O00512</id>
<label>BCL9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-7286259">
<id>A1Z199</id>
<label>BCR/ABL fusion</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-307461">
<id>Q9Y297</id>
<label>BTRC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-930143">
<id>Q6P1J9</id>
<label>CDC73</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-727477">
<id>P12830</id>
<label>CDH1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>14</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-2256711">
<id>P19022</id>
<label>CDH2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-2903122">
<id>P33151</id>
<label>CDH5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-81215">
<id>Q92793</id>
<label>CREBBP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-701918">
<id>P35221</id>
<label>CTNNA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-3937546">
<id>Q9UI47</id>
<label>CTNNA3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-21980640">
<id>Q9UI47-1</id>
<label>CTNNA3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-747082">
<id>Q9NSA3</id>
<label>CTNNBIP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-3951744">
<id>Q9NYF0</id>
<label>DACT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-719459">
<id>P26358</id>
<label>DNMT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-2834611">
<id>P18146</id>
<label>EGR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-489887">
<id>P50402</id>
<label>EMD</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-702104">
<id>P29317</id>
<label>EPHA2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-355189">
<id>Q9UKB1</id>
<label>FBXW11</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-4399465">
<id>Q96AC1</id>
<label>FERMT2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>13</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-1028277">
<id>P11362</id>
<label>FGFR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-741760">
<id>P49789</id>
<label>FHIT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-1026718">
<id>P17948</id>
<label>FLT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-866480">
<id>Q08050</id>
<label>FOXM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>16</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-7251368">
<id>Q9BZE0</id>
<label>GLIS2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-373586">
<id>P49841</id>
<label>GSK3B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>19</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-301697">
<id>Q9UBN7</id>
<label>HDAC6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-447269">
<id>Q16665</id>
<label>HIF1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-466029">
<id>P42858</id>
<label>HTT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-475981">
<id>P08069</id>
<label>IGF1R</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-297509">
<id>P46940</id>
<label>IQGAP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-8607681">
<id>O75564</id>
<label>JRK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-702484">
<id>P14923</id>
<label>JUP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-2556221">
<id>Q14678</id>
<label>KANK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-2683809">
<id>Q2LD37</id>
<label>KIAA1109</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-926131">
<id>Q9UJU2</id>
<label>LEF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-932432">
<id>Q8WVC0</id>
<label>LEO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-373144">
<id>Q9GZQ8</id>
<label>MAP1LC3B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-1104952">
<id>P55197</id>
<label>MLLT10</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-716486">
<id>Q92597</id>
<label>NDRG1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-300010">
<id>P19838</id>
<label>NFKB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-1391623">
<id>P29474</id>
<label>NOS3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-15960777">
<id>O00482-1</id>
<label>NR5A2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-915016">
<id>P49757</id>
<label>NUMB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-10692196">
<id>P49757-3</id>
<label>NUMB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-81968">
<id>Q8TEW0</id>
<label>PARD3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-716404">
<id>P16284</id>
<label>PECAM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-1175211">
<id>Q99697</id>
<label>PITX2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-353408">
<id>P14618</id>
<label>PKM</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-4304679">
<id>P14618-1</id>
<label>PKM</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-2860297">
<id>Q03431</id>
<label>PTH1R</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-2803245">
<id>Q13308</id>
<label>PTK7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-1341">
<id>P08575</id>
<label>PTPRC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-2258115">
<id>P23470</id>
<label>PTPRG</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-2264500">
<id>Q12913</id>
<label>PTPRJ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-702209">
<id>P49023</id>
<label>PXN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-73886">
<id>Q04206</id>
<label>RELA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-925990">
<id>Q13761</id>
<label>RUNX3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-353675">
<id>Q9Y265</id>
<label>RUVBL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-743747">
<id>Q01826</id>
<label>SATB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-307486">
<id>P63208</id>
<label>SKP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-9106753">
<id>Q9H6I2</id>
<label>SOX17</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-621482">
<id>P12931</id>
<label>SRC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-533224">
<id>P15884</id>
<label>TCF4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>22</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-2119465">
<id>P36402</id>
<label>TCF7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-924724">
<id>Q9NQB0</id>
<label>TCF7L2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>27</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-1772203">
<id>O14746</id>
<label>TERT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-1051794">
<id>Q9UKE5</id>
<label>TNIK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-539628">
<id>P11388</id>
<label>TOP2A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-77642">
<id>Q13625</id>
<label>TP53BP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-358329">
<id>O95071</id>
<label>UBR5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-747743">
<id>Q9GZV5</id>
<label>WWTR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-1044059">
<id>P46937</id>
<label>YAP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>13</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-6558686">
<id>P46937-3</id>
<label>YAP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-2365912">
<id>O35625</id>
<label>Axin1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-1037449">
<id>Q9YGY0</id>
<label>axin1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-79998">
<id>P33724</id>
<label>CAV1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-647895">
<id>P26231</id>
<label>Ctnna1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-491541">
<id>P18012</id>
<label>ipaC</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-984464">
<id>P27782</id>
<label>Lef1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-6142879">
<id>Q9JHQ5</id>
<label>Lztfl1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-16110594">
<id>Q01887</id>
<label>Ryk</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-1161647">
<id>Q9DBG9</id>
<label>Tax1bp3</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491549">
<id>P35222</id>
</interactant>
<interactant intactId="EBI-1211920">
<id>Q9EPK5</id>
<label>Wwtr1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="75 86">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="72 75 82 83 86">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="15">Cytoplasm</location>
<location evidence="15">Cytoskeleton</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="16">Cell junction</location>
<location evidence="16">Adherens junction</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="15">Cell junction</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="72">Cell membrane</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>Cytoskeleton</location>
<location>Microtubule organizing center</location>
<location>Centrosome</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>Cytoskeleton</location>
<location>Spindle pole</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="16">Cell junction</location>
<location evidence="16">Synapse</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="16">Cytoplasm</location>
<location evidence="16">Cytoskeleton</location>
<location evidence="16">Cilium basal body</location>
</subcellularLocation>
<text evidence="15 75">Colocalized with RAPGEF2 and TJP1 at cell-cell contacts (By similarity). Cytoplasmic when it is unstabilized (high level of phosphorylation) or bound to CDH1. Translocates to the nucleus when it is stabilized (low level of phosphorylation). Interaction with GLIS2 and MUC1 promotes nuclear translocation. Interaction with EMD inhibits nuclear localization. The majority of beta-catenin is localized to the cell membrane. In interphase, colocalizes with CROCC between CEP250 puncta at the proximal end of centrioles, and this localization is dependent on CROCC and CEP250. In mitosis, when NEK2 activity increases, it localizes to centrosomes at spindle poles independent of CROCC. Colocalizes with CDK5 in the cell-cell contacts and plasma membrane of undifferentiated and differentiated neuroblastoma cells. Interaction with FAM53B promotes translocation to the nucleus (PubMed:25183871).</text>
</comment>
<comment type="tissue specificity">
<text evidence="29 47 50 83">Expressed in several hair follicle cell types: basal and peripheral matrix cells, and cells of the outer and inner root sheaths. Expressed in colon. Present in cortical neurons (at protein level). Expressed in breast cancer tissues (at protein level) (PubMed:29367600).</text>
</comment>
<comment type="PTM">
<text evidence="14 23 24 33 34 35 41 47 53 61 63 66 74">Phosphorylation at Ser-552 by AMPK promotes stabilizion of the protein, enhancing TCF/LEF-mediated transcription (By similarity). Phosphorylation by GSK3B requires prior phosphorylation of Ser-45 by another kinase. Phosphorylation proceeds then from Thr-41 to Ser-37 and Ser-33. Phosphorylated by NEK2. EGF stimulates tyrosine phosphorylation. Phosphorylation on Tyr-654 decreases CDH1 binding and enhances TBP binding. Phosphorylated on Ser-33 and Ser-37 by HIPK2 and GSK3B, this phosphorylation triggers proteasomal degradation (PubMed:25169422). Phosphorylation on Ser-191 and Ser-246 by CDK5. Phosphorylation by CDK2 regulates insulin internalization. Phosphorylation by PTK6 at Tyr-64, Tyr-142, Tyr-331 and/or Tyr-333 with the predominant site at Tyr-64 is not essential for inhibition of transcriptional activity.</text>
</comment>
<comment type="PTM">
<text evidence="16 25 26 35 63">Ubiquitinated by the SCF(BTRC) E3 ligase complex when phosphorylated by GSK3B, leading to its degradation (PubMed:12077367). Ubiquitinated by a E3 ubiquitin ligase complex containing UBE2D1, SIAH1, CACYBP/SIP, SKP1, APC and TBL1X, leading to its subsequent proteasomal degradation (PubMed:11389839, PubMed:11389840, PubMed:20307497). Ubiquitinated and degraded following interaction with SOX9 (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="16">S-nitrosylation at Cys-619 within adherens junctions promotes VEGF-induced, NO-dependent endothelial cell permeability by disrupting interaction with E-cadherin, thus mediating disassembly adherens junctions.</text>
</comment>
<comment type="PTM">
<text evidence="72">O-glycosylation at Ser-23 decreases nuclear localization and transcriptional activity, and increases localization to the plasma membrane and interaction with E-cadherin CDH1.</text>
</comment>
<comment type="PTM">
<text evidence="73">Deacetylated at Lys-49 by SIRT1.</text>
</comment>
<comment type="disease" evidence="89">
<disease id="DI-01359">
<name>Colorectal cancer</name>
<acronym>CRC</acronym>
<description>A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history.</description>
<dbReference type="MIM" id="114500"/>
</disease>
<text>The gene represented in this entry may be involved in disease pathogenesis.</text>
</comment>
<comment type="disease">
<text>Activating mutations in CTNNB1 have oncogenic activity resulting in tumor development. Somatic mutations are found in various tumor types, including colon cancers, ovarian and prostate carcinomas, hepatoblastoma (HB), hepatocellular carcinoma (HCC). HBs are malignant embryonal tumors mainly affecting young children in the first three years of life.</text>
</comment>
<comment type="disease" evidence="17 29 33">
<disease id="DI-02167">
<name>Pilomatrixoma</name>
<acronym>PTR</acronym>
<description>Common benign skin tumor.</description>
<dbReference type="MIM" id="132600"/>
</disease>
<text>The gene represented in this entry is involved in disease pathogenesis.</text>
</comment>
<comment type="disease" evidence="22 33">
<disease id="DI-01958">
<name>Medulloblastoma</name>
<acronym>MDB</acronym>
<description>Malignant, invasive embryonal tumor of the cerebellum with a preferential manifestation in children.</description>
<dbReference type="MIM" id="155255"/>
</disease>
<text>The gene represented in this entry may be involved in disease pathogenesis.</text>
</comment>
<comment type="disease" evidence="18">
<disease id="DI-01655">
<name>Ovarian cancer</name>
<acronym>OC</acronym>
<description>The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease.</description>
<dbReference type="MIM" id="167000"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<text>A chromosomal aberration involving CTNNB1 is found in salivary gland pleiomorphic adenomas, the most common benign epithelial tumors of the salivary gland. Translocation t(3;8)(p21;q12) with PLAG1.</text>
</comment>
<comment type="disease" evidence="27">
<disease id="DI-03213">
<name>Mesothelioma, malignant</name>
<acronym>MESOM</acronym>
<description>An aggressive neoplasm of the serosal lining of the chest. It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos.</description>
<dbReference type="MIM" id="156240"/>
</disease>
<text>The gene represented in this entry may be involved in disease pathogenesis.</text>
</comment>
<comment type="disease" evidence="71 77 80">
<disease id="DI-03652">
<name>Neurodevelopmental disorder with spastic diplegia and visual defects</name>
<acronym>NEDSDV</acronym>
<description>An autosomal dominant disorder characterized by global developmental delay, severe intellectual disability with absent or very limited speech, microcephaly, spasticity, and visual abnormalities.</description>
<dbReference type="MIM" id="615075"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="81">
<disease id="DI-05042">
<name>Vitreoretinopathy, exudative 7</name>
<acronym>EVR7</acronym>
<description>A form of exudative vitreoretinopathy, a disorder of the retinal vasculature characterized by an abrupt cessation of growth of peripheral capillaries, leading to an avascular peripheral retina. This may lead to compensatory retinal neovascularization, which is thought to be induced by hypoxia from the initial avascular insult. New vessels are prone to leakage and rupture causing exudates and bleeding, followed by scarring, retinal detachment and blindness. Clinical features can be highly variable, even within the same family. Patients with mild forms of the disease are asymptomatic, and their only disease related abnormality is an arc of avascular retina in the extreme temporal periphery.</description>
<dbReference type="MIM" id="617572"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="92">Belongs to the beta-catenin family.</text>
</comment>
<comment type="sequence caution" evidence="92">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="AAG35511" version="1"/>
</conflict>
<text>Probable cloning artifact.</text>
</comment>
<comment type="sequence caution" evidence="92">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAB93475" version="1"/>
</conflict>
<text>Truncated N-terminus.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/CTNNB1ID71.html"/>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/ctnnb1/"/>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/Beta-catenin"/>
<text>Beta-catenin entry</text>
</comment>
<dbReference type="EMBL" id="X87838">
<property type="protein sequence ID" value="CAA61107.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Z19054">
<property type="protein sequence ID" value="CAA79497.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF130085">
<property type="protein sequence ID" value="AAG35511.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY463360">
<property type="protein sequence ID" value="AAR18817.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK289932">
<property type="protein sequence ID" value="BAF82621.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC104307">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471055">
<property type="protein sequence ID" value="EAW64625.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC058926">
<property type="protein sequence ID" value="AAH58926.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY081165">
<property type="protein sequence ID" value="AAL89457.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AB062292">
<property type="protein sequence ID" value="BAB93475.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS2694.1"/>
<dbReference type="PIR" id="A38973">
<property type="entry name" value="A38973"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001091679.1">
<property type="nucleotide sequence ID" value="NM_001098209.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001091680.1">
<property type="nucleotide sequence ID" value="NM_001098210.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001895.1">
<property type="nucleotide sequence ID" value="NM_001904.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005264943.1">
<property type="nucleotide sequence ID" value="XM_005264886.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016861227.1">
<property type="nucleotide sequence ID" value="XM_017005738.1"/>
</dbReference>
<dbReference type="PDB" id="1G3J">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/C=133-664"/>
</dbReference>
<dbReference type="PDB" id="1JDH">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=135-663"/>
</dbReference>
<dbReference type="PDB" id="1JPW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B/C=131-670"/>
</dbReference>
<dbReference type="PDB" id="1LUJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=150-663"/>
</dbReference>
<dbReference type="PDB" id="1P22">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.95"/>
<property type="chains" value="C=19-44"/>
</dbReference>
<dbReference type="PDB" id="1QZ7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=133-665"/>
</dbReference>
<dbReference type="PDB" id="1T08">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=146-664"/>
</dbReference>
<dbReference type="PDB" id="1TH1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=133-664"/>
</dbReference>
<dbReference type="PDB" id="2G57">
<property type="method" value="NMR"/>
<property type="chains" value="A=19-44"/>
</dbReference>
<dbReference type="PDB" id="2GL7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/D=138-686"/>
</dbReference>
<dbReference type="PDB" id="2Z6H">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=138-781"/>
</dbReference>
<dbReference type="PDB" id="3DIW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="C/D=772-781"/>
</dbReference>
<dbReference type="PDB" id="3FQN">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="C=30-39"/>
</dbReference>
<dbReference type="PDB" id="3FQR">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="C=30-39"/>
</dbReference>
<dbReference type="PDB" id="3SL9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B/E/G=141-305"/>
</dbReference>
<dbReference type="PDB" id="3SLA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B/C/D/E=141-306"/>
</dbReference>
<dbReference type="PDB" id="3TX7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.76"/>
<property type="chains" value="A=138-663"/>
</dbReference>
<dbReference type="PDB" id="4DJS">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.03"/>
<property type="chains" value="A=148-665"/>
</dbReference>
<dbReference type="PDB" id="6M90">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.05"/>
<property type="chains" value="C=17-48"/>
</dbReference>
<dbReference type="PDB" id="6M91">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="C=17-48"/>
</dbReference>
<dbReference type="PDB" id="6M92">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="C=17-48"/>
</dbReference>
<dbReference type="PDB" id="6M93">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="C=17-48"/>
</dbReference>
<dbReference type="PDB" id="6M94">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="C=17-48"/>
</dbReference>
<dbReference type="PDB" id="6O9B">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="C=41-49"/>
</dbReference>
<dbReference type="PDB" id="6O9C">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.45"/>
<property type="chains" value="C=41-49"/>
</dbReference>
<dbReference type="PDB" id="6WLX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="B=671-677"/>
</dbReference>
<dbReference type="PDB" id="6WNX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="C/F/I=31-39"/>
</dbReference>
<dbReference type="PDBsum" id="1G3J"/>
<dbReference type="PDBsum" id="1JDH"/>
<dbReference type="PDBsum" id="1JPW"/>
<dbReference type="PDBsum" id="1LUJ"/>
<dbReference type="PDBsum" id="1P22"/>
<dbReference type="PDBsum" id="1QZ7"/>
<dbReference type="PDBsum" id="1T08"/>
<dbReference type="PDBsum" id="1TH1"/>
<dbReference type="PDBsum" id="2G57"/>
<dbReference type="PDBsum" id="2GL7"/>
<dbReference type="PDBsum" id="2Z6H"/>
<dbReference type="PDBsum" id="3DIW"/>
<dbReference type="PDBsum" id="3FQN"/>
<dbReference type="PDBsum" id="3FQR"/>
<dbReference type="PDBsum" id="3SL9"/>
<dbReference type="PDBsum" id="3SLA"/>
<dbReference type="PDBsum" id="3TX7"/>
<dbReference type="PDBsum" id="4DJS"/>
<dbReference type="PDBsum" id="6M90"/>
<dbReference type="PDBsum" id="6M91"/>
<dbReference type="PDBsum" id="6M92"/>
<dbReference type="PDBsum" id="6M93"/>
<dbReference type="PDBsum" id="6M94"/>
<dbReference type="PDBsum" id="6O9B"/>
<dbReference type="PDBsum" id="6O9C"/>
<dbReference type="PDBsum" id="6WLX"/>
<dbReference type="PDBsum" id="6WNX"/>
<dbReference type="SMR" id="P35222"/>
<dbReference type="BioGRID" id="107880">
<property type="interactions" value="707"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-316">
<property type="entry name" value="beta1-catenin - LEF1 complex"/>
</dbReference>
<dbReference type="CORUM" id="P35222"/>
<dbReference type="DIP" id="DIP-122N"/>
<dbReference type="IntAct" id="P35222">
<property type="interactions" value="233"/>
</dbReference>
<dbReference type="MINT" id="P35222"/>
<dbReference type="STRING" id="9606.ENSP00000344456"/>
<dbReference type="BindingDB" id="P35222"/>
<dbReference type="ChEMBL" id="CHEMBL5866"/>
<dbReference type="DrugBank" id="DB03904">
<property type="generic name" value="Urea"/>
</dbReference>
<dbReference type="GlyGen" id="P35222">
<property type="glycosylation" value="1 site"/>
</dbReference>
<dbReference type="iPTMnet" id="P35222"/>
<dbReference type="MetOSite" id="P35222"/>
<dbReference type="PhosphoSitePlus" id="P35222"/>
<dbReference type="SwissPalm" id="P35222"/>
<dbReference type="BioMuta" id="CTNNB1"/>
<dbReference type="DMDM" id="461854"/>
<dbReference type="CPTAC" id="CPTAC-1745"/>
<dbReference type="EPD" id="P35222"/>
<dbReference type="jPOST" id="P35222"/>
<dbReference type="MassIVE" id="P35222"/>
<dbReference type="MaxQB" id="P35222"/>
<dbReference type="PaxDb" id="P35222"/>
<dbReference type="PeptideAtlas" id="P35222"/>
<dbReference type="PRIDE" id="P35222"/>
<dbReference type="ABCD" id="P35222">
<property type="antibodies" value="2 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="3432">
<property type="antibodies" value="4777 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="1499"/>
<dbReference type="Ensembl" id="ENST00000349496">
<property type="protein sequence ID" value="ENSP00000344456"/>
<property type="gene ID" value="ENSG00000168036"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000396183">
<property type="protein sequence ID" value="ENSP00000379486"/>
<property type="gene ID" value="ENSG00000168036"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000396185">
<property type="protein sequence ID" value="ENSP00000379488"/>
<property type="gene ID" value="ENSG00000168036"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000405570">
<property type="protein sequence ID" value="ENSP00000385604"/>
<property type="gene ID" value="ENSG00000168036"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000431914">
<property type="protein sequence ID" value="ENSP00000412219"/>
<property type="gene ID" value="ENSG00000168036"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000433400">
<property type="protein sequence ID" value="ENSP00000387455"/>
<property type="gene ID" value="ENSG00000168036"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000441708">
<property type="protein sequence ID" value="ENSP00000401599"/>
<property type="gene ID" value="ENSG00000168036"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000450969">
<property type="protein sequence ID" value="ENSP00000409302"/>
<property type="gene ID" value="ENSG00000168036"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000642248">
<property type="protein sequence ID" value="ENSP00000495244"/>
<property type="gene ID" value="ENSG00000168036"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000642315">
<property type="protein sequence ID" value="ENSP00000495076"/>
<property type="gene ID" value="ENSG00000168036"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000642426">
<property type="protein sequence ID" value="ENSP00000495719"/>
<property type="gene ID" value="ENSG00000168036"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000642992">
<property type="protein sequence ID" value="ENSP00000496385"/>
<property type="gene ID" value="ENSG00000168036"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000643031">
<property type="protein sequence ID" value="ENSP00000495450"/>
<property type="gene ID" value="ENSG00000168036"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000643297">
<property type="protein sequence ID" value="ENSP00000494677"/>
<property type="gene ID" value="ENSG00000168036"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000643541">
<property type="protein sequence ID" value="ENSP00000494411"/>
<property type="gene ID" value="ENSG00000168036"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000643977">
<property type="protein sequence ID" value="ENSP00000494053"/>
<property type="gene ID" value="ENSG00000168036"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000643992">
<property type="protein sequence ID" value="ENSP00000493610"/>
<property type="gene ID" value="ENSG00000168036"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000644867">
<property type="protein sequence ID" value="ENSP00000495992"/>
<property type="gene ID" value="ENSG00000168036"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000645210">
<property type="protein sequence ID" value="ENSP00000496180"/>
<property type="gene ID" value="ENSG00000168036"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000645320">
<property type="protein sequence ID" value="ENSP00000495360"/>
<property type="gene ID" value="ENSG00000168036"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000645982">
<property type="protein sequence ID" value="ENSP00000494845"/>
<property type="gene ID" value="ENSG00000168036"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000646369">
<property type="protein sequence ID" value="ENSP00000494914"/>
<property type="gene ID" value="ENSG00000168036"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000646725">
<property type="protein sequence ID" value="ENSP00000496021"/>
<property type="gene ID" value="ENSG00000168036"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000647390">
<property type="protein sequence ID" value="ENSP00000493533"/>
<property type="gene ID" value="ENSG00000168036"/>
</dbReference>
<dbReference type="GeneID" id="1499"/>
<dbReference type="KEGG" id="hsa:1499"/>
<dbReference type="UCSC" id="uc003ckp.3">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="1499"/>
<dbReference type="DisGeNET" id="1499"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000168036.16"/>
<dbReference type="GeneCards" id="CTNNB1"/>
<dbReference type="HGNC" id="HGNC:2514">
<property type="gene designation" value="CTNNB1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000168036">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="CTNNB1"/>
<dbReference type="MIM" id="114500">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="116806">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="132600">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="155255">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="156240">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="167000">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="181030">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="615075">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="617572">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P35222"/>
<dbReference type="OpenTargets" id="ENSG00000168036"/>
<dbReference type="Orphanet" id="210159">
<property type="disease" value="Adult hepatocellular carcinoma"/>
</dbReference>
<dbReference type="Orphanet" id="54595">
<property type="disease" value="Craniopharyngioma"/>
</dbReference>
<dbReference type="Orphanet" id="873">
<property type="disease" value="Desmoid tumor"/>
</dbReference>
<dbReference type="Orphanet" id="891">
<property type="disease" value="Familial exudative vitreoretinopathy"/>
</dbReference>
<dbReference type="Orphanet" id="569248">
<property type="disease" value="Microcystic stromal tumor"/>
</dbReference>
<dbReference type="Orphanet" id="85142">
<property type="disease" value="NON RARE IN EUROPE: Aldosterone-producing adenoma"/>
</dbReference>
<dbReference type="Orphanet" id="33402">
<property type="disease" value="Pediatric hepatocellular carcinoma"/>
</dbReference>
<dbReference type="Orphanet" id="91414">
<property type="disease" value="Pilomatrixoma"/>
</dbReference>
<dbReference type="Orphanet" id="404473">
<property type="disease" value="Severe intellectual disability-progressive spastic diplegia syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA27013"/>
<dbReference type="eggNOG" id="KOG4203">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000155471"/>
<dbReference type="InParanoid" id="P35222"/>
<dbReference type="KO" id="K02105"/>
<dbReference type="OMA" id="MAWNEXP"/>
<dbReference type="OrthoDB" id="321213at2759"/>
<dbReference type="PhylomeDB" id="P35222"/>
<dbReference type="TreeFam" id="TF317997"/>
<dbReference type="PathwayCommons" id="P35222"/>
<dbReference type="Reactome" id="R-HSA-195253">
<property type="pathway name" value="Degradation of beta-catenin by the destruction complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-196299">
<property type="pathway name" value="Beta-catenin phosphorylation cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-201681">
<property type="pathway name" value="TCF dependent signaling in response to WNT"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-201722">
<property type="pathway name" value="Formation of the beta-catenin:TCF transactivating complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3134973">
<property type="pathway name" value="LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-351906">
<property type="pathway name" value="Apoptotic cleavage of cell adhesion proteins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3769402">
<property type="pathway name" value="Deactivation of the beta-catenin transactivating complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-381771">
<property type="pathway name" value="Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4086398">
<property type="pathway name" value="Ca2+ pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-418990">
<property type="pathway name" value="Adherens junctions interactions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4411364">
<property type="pathway name" value="Binding of TCF/LEF:CTNNB1 to target gene promoters"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4641262">
<property type="pathway name" value="Disassembly of the destruction complex and recruitment of AXIN to the membrane"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5218920">
<property type="pathway name" value="VEGFR2 mediated vascular permeability"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-525793">
<property type="pathway name" value="Myogenesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5339716">
<property type="pathway name" value="Misspliced GSK3beta mutants stabilize beta-catenin"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5358747">
<property type="pathway name" value="S33 mutants of beta-catenin aren't phosphorylated"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5358749">
<property type="pathway name" value="S37 mutants of beta-catenin aren't phosphorylated"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5358751">
<property type="pathway name" value="S45 mutants of beta-catenin aren't phosphorylated"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5358752">
<property type="pathway name" value="T41 mutants of beta-catenin aren't phosphorylated"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5626467">
<property type="pathway name" value="RHO GTPases activate IQGAPs"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8853884">
<property type="pathway name" value="Transcriptional Regulation by VENTX"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8876493">
<property type="pathway name" value="InlA-mediated entry of Listeria monocytogenes into host cells"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8951430">
<property type="pathway name" value="RUNX3 regulates WNT signaling"/>
</dbReference>
<dbReference type="SignaLink" id="P35222"/>
<dbReference type="SIGNOR" id="P35222"/>
<dbReference type="BioGRID-ORCS" id="1499">
<property type="hits" value="89 hits in 885 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="CTNNB1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P35222"/>
<dbReference type="GeneWiki" id="Beta-catenin"/>
<dbReference type="GenomeRNAi" id="1499"/>
<dbReference type="Pharos" id="P35222">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:P35222"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 3"/>
</dbReference>
<dbReference type="RNAct" id="P35222">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000168036">
<property type="expression patterns" value="Expressed in adrenal tissue and 251 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P35222">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P35222">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005912">
<property type="term" value="C:adherens junction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045177">
<property type="term" value="C:apical part of cell"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016327">
<property type="term" value="C:apicolateral plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016323">
<property type="term" value="C:basolateral plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030877">
<property type="term" value="C:beta-catenin destruction complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1990907">
<property type="term" value="C:beta-catenin-TCF complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="FlyBase"/>
</dbReference>
<dbReference type="GO" id="GO:0070369">
<property type="term" value="C:beta-catenin-TCF7L2 complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005923">
<property type="term" value="C:bicellular tight junction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016342">
<property type="term" value="C:catenin complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005938">
<property type="term" value="C:cell cortex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030054">
<property type="term" value="C:cell junction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071944">
<property type="term" value="C:cell periphery"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005911">
<property type="term" value="C:cell-cell junction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005813">
<property type="term" value="C:centrosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005916">
<property type="term" value="C:fascia adherens"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016600">
<property type="term" value="C:flotillin complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005925">
<property type="term" value="C:focal adhesion"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030027">
<property type="term" value="C:lamellipodium"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016328">
<property type="term" value="C:lateral plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031528">
<property type="term" value="C:microvillus membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005719">
<property type="term" value="C:nuclear euchromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045211">
<property type="term" value="C:postsynaptic membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0098831">
<property type="term" value="C:presynaptic active zone cytoplasmic component"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042734">
<property type="term" value="C:presynaptic membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0032993">
<property type="term" value="C:protein-DNA complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0098685">
<property type="term" value="C:Schaffer collateral - CA1 synapse"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034750">
<property type="term" value="C:Scrib-APC-beta-catenin complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000922">
<property type="term" value="C:spindle pole"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0045202">
<property type="term" value="C:synapse"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005667">
<property type="term" value="C:transcription regulator complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1990909">
<property type="term" value="C:Wnt signalosome"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030018">
<property type="term" value="C:Z disc"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045294">
<property type="term" value="F:alpha-catenin binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008013">
<property type="term" value="F:beta-catenin binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045296">
<property type="term" value="F:cadherin binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0097718">
<property type="term" value="F:disordered domain specific binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030331">
<property type="term" value="F:estrogen receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070411">
<property type="term" value="F:I-SMAD binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0044325">
<property type="term" value="F:ion channel binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019900">
<property type="term" value="F:kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035257">
<property type="term" value="F:nuclear hormone receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008022">
<property type="term" value="F:protein C-terminus binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019903">
<property type="term" value="F:protein phosphatase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070491">
<property type="term" value="F:repressing transcription factor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001102">
<property type="term" value="F:RNA polymerase II activating transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001085">
<property type="term" value="F:RNA polymerase II transcription factor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046332">
<property type="term" value="F:SMAD binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003713">
<property type="term" value="F:transcription coactivator activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034333">
<property type="term" value="P:adherens junction assembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0009948">
<property type="term" value="P:anterior/posterior axis specification"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0036520">
<property type="term" value="P:astrocyte-dopaminergic neuron signaling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1904886">
<property type="term" value="P:beta-catenin destruction complex disassembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:1904837">
<property type="term" value="P:beta-catenin-TCF complex assembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045453">
<property type="term" value="P:bone resorption"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001569">
<property type="term" value="P:branching involved in blood vessel morphogenesis"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001658">
<property type="term" value="P:branching involved in ureteric bud morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060070">
<property type="term" value="P:canonical Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044338">
<property type="term" value="P:canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1904954">
<property type="term" value="P:canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0044336">
<property type="term" value="P:canonical Wnt signaling pathway involved in negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0061324">
<property type="term" value="P:canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0044334">
<property type="term" value="P:canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007155">
<property type="term" value="P:cell adhesion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001708">
<property type="term" value="P:cell fate specification"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048469">
<property type="term" value="P:cell maturation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000904">
<property type="term" value="P:cell morphogenesis involved in differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0098609">
<property type="term" value="P:cell-cell adhesion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007160">
<property type="term" value="P:cell-matrix adhesion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071363">
<property type="term" value="P:cellular response to growth factor stimulus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071681">
<property type="term" value="P:cellular response to indole-3-methanol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0022009">
<property type="term" value="P:central nervous system vasculogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007268">
<property type="term" value="P:chemical synaptic transmission"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048096">
<property type="term" value="P:chromatin-mediated maintenance of transcription"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0061550">
<property type="term" value="P:cranial ganglion development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1904888">
<property type="term" value="P:cranial skeletal system development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1990791">
<property type="term" value="P:dorsal root ganglion development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009950">
<property type="term" value="P:dorsal/ventral axis specification"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007398">
<property type="term" value="P:ectoderm development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000578">
<property type="term" value="P:embryonic axis specification"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1990403">
<property type="term" value="P:embryonic brain development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042733">
<property type="term" value="P:embryonic digit morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048617">
<property type="term" value="P:embryonic foregut morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035115">
<property type="term" value="P:embryonic forelimb morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035050">
<property type="term" value="P:embryonic heart tube development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035116">
<property type="term" value="P:embryonic hindlimb morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0036023">
<property type="term" value="P:embryonic skeletal limb joint morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001711">
<property type="term" value="P:endodermal cell fate commitment"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0061154">
<property type="term" value="P:endothelial tube morphogenesis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035635">
<property type="term" value="P:entry of bacterium into host cell"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0060742">
<property type="term" value="P:epithelial cell differentiation involved in prostate gland development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001837">
<property type="term" value="P:epithelial to mesenchymal transition"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="HGNC-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060441">
<property type="term" value="P:epithelial tube branching involved in lung morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0061198">
<property type="term" value="P:fungiform papilla formation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001702">
<property type="term" value="P:gastrulation with mouth forming second"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035112">
<property type="term" value="P:genitalia morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007403">
<property type="term" value="P:glial cell fate determination"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035315">
<property type="term" value="P:hair cell differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031069">
<property type="term" value="P:hair follicle morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060789">
<property type="term" value="P:hair follicle placode formation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030902">
<property type="term" value="P:hindbrain development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001701">
<property type="term" value="P:in utero embryonic development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0021819">
<property type="term" value="P:layer formation in cerebral cortex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002089">
<property type="term" value="P:lens morphogenesis in camera-type eye"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060479">
<property type="term" value="P:lung cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060492">
<property type="term" value="P:lung induction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060484">
<property type="term" value="P:lung-associated mesenchyme development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030539">
<property type="term" value="P:male genitalia development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060916">
<property type="term" value="P:mesenchymal cell proliferation involved in lung development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003338">
<property type="term" value="P:metanephros morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1904948">
<property type="term" value="P:midbrain dopaminergic neuron differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016525">
<property type="term" value="P:negative regulation of angiogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2001234">
<property type="term" value="P:negative regulation of apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032331">
<property type="term" value="P:negative regulation of chondrocyte differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003340">
<property type="term" value="P:negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045976">
<property type="term" value="P:negative regulation of mitotic cell cycle, embryonic"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048715">
<property type="term" value="P:negative regulation of oligodendrocyte differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045671">
<property type="term" value="P:negative regulation of osteoclast differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1903204">
<property type="term" value="P:negative regulation of oxidative stress-induced neuron death"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033234">
<property type="term" value="P:negative regulation of protein sumoylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0072079">
<property type="term" value="P:nephron tubule formation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001840">
<property type="term" value="P:neural plate development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001764">
<property type="term" value="P:neuron migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1990138">
<property type="term" value="P:neuron projection extension"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042475">
<property type="term" value="P:odontogenesis of dentin-containing tooth"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048599">
<property type="term" value="P:oocyte development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030316">
<property type="term" value="P:osteoclast differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060066">
<property type="term" value="P:oviduct development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031016">
<property type="term" value="P:pancreas development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043065">
<property type="term" value="P:positive regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904501">
<property type="term" value="P:positive regulation of chromatin-mediated maintenance of transcription"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1904798">
<property type="term" value="P:positive regulation of core promoter binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000017">
<property type="term" value="P:positive regulation of determination of dorsal identity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051091">
<property type="term" value="P:positive regulation of DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000144">
<property type="term" value="P:positive regulation of DNA-templated transcription, initiation"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045603">
<property type="term" value="P:positive regulation of endothelial cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060769">
<property type="term" value="P:positive regulation of epithelial cell proliferation involved in prostate gland development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010718">
<property type="term" value="P:positive regulation of epithelial to mesenchymal transition"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0045743">
<property type="term" value="P:positive regulation of fibroblast growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010909">
<property type="term" value="P:positive regulation of heparan sulfate proteoglycan biosynthetic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051571">
<property type="term" value="P:positive regulation of histone H3-K4 methylation"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043123">
<property type="term" value="P:positive regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043410">
<property type="term" value="P:positive regulation of MAPK cascade"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002053">
<property type="term" value="P:positive regulation of mesenchymal cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051149">
<property type="term" value="P:positive regulation of muscle cell differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0002052">
<property type="term" value="P:positive regulation of neuroblast proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043525">
<property type="term" value="P:positive regulation of neuron apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045669">
<property type="term" value="P:positive regulation of osteoblast differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048643">
<property type="term" value="P:positive regulation of skeletal muscle tissue development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051973">
<property type="term" value="P:positive regulation of telomerase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032212">
<property type="term" value="P:positive regulation of telomere maintenance via telomerase"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032968">
<property type="term" value="P:positive regulation of transcription elongation from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032481">
<property type="term" value="P:positive regulation of type I interferon production"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043161">
<property type="term" value="P:proteasome-mediated ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034394">
<property type="term" value="P:protein localization to cell surface"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000209">
<property type="term" value="P:protein polyubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009954">
<property type="term" value="P:proximal/distal pattern formation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045765">
<property type="term" value="P:regulation of angiogenesis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090279">
<property type="term" value="P:regulation of calcium ion import"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060828">
<property type="term" value="P:regulation of canonical Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030997">
<property type="term" value="P:regulation of centriole-centriole cohesion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070602">
<property type="term" value="P:regulation of centromeric sister chromatid cohesion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1904793">
<property type="term" value="P:regulation of euchromatin binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048145">
<property type="term" value="P:regulation of fibroblast proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031641">
<property type="term" value="P:regulation of myelination"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0072182">
<property type="term" value="P:regulation of nephron tubule epithelial cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050767">
<property type="term" value="P:regulation of neurogenesis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000008">
<property type="term" value="P:regulation of protein localization to cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003266">
<property type="term" value="P:regulation of secondary heart field cardioblast proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048660">
<property type="term" value="P:regulation of smooth muscle cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042129">
<property type="term" value="P:regulation of T cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051884">
<property type="term" value="P:regulation of timing of anagen"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0072053">
<property type="term" value="P:renal inner medulla development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0072054">
<property type="term" value="P:renal outer medulla development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0072033">
<property type="term" value="P:renal vesicle formation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042493">
<property type="term" value="P:response to drug"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032355">
<property type="term" value="P:response to estradiol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051145">
<property type="term" value="P:smooth muscle cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019827">
<property type="term" value="P:stem cell population maintenance"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0061549">
<property type="term" value="P:sympathetic ganglion development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050808">
<property type="term" value="P:synapse organization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0097091">
<property type="term" value="P:synaptic vesicle clustering"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048489">
<property type="term" value="P:synaptic vesicle transport"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033077">
<property type="term" value="P:T cell differentiation in thymus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048538">
<property type="term" value="P:thymus development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060440">
<property type="term" value="P:trachea formation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0016055">
<property type="term" value="P:Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007223">
<property type="term" value="P:Wnt signaling pathway, calcium modulating pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="DisProt" id="DP01119"/>
<dbReference type="Gene3D" id="1.25.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00039"/>
<dbReference type="InterPro" id="IPR011989">
<property type="entry name" value="ARM-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR016024">
<property type="entry name" value="ARM-type_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR000225">
<property type="entry name" value="Armadillo"/>
</dbReference>
<dbReference type="InterPro" id="IPR013284">
<property type="entry name" value="Beta-catenin"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR45976">
<property type="entry name" value="PTHR45976"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00514">
<property type="entry name" value="Arm"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="PRINTS" id="PR01869">
<property type="entry name" value="BCATNINFAMLY"/>
</dbReference>
<dbReference type="SMART" id="SM00185">
<property type="entry name" value="ARM"/>
<property type="match status" value="12"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48371">
<property type="entry name" value="SSF48371"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50176">
<property type="entry name" value="ARM_REPEAT"/>
<property type="match status" value="9"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0130">Cell adhesion</keyword>
<keyword id="KW-0965">Cell junction</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0966">Cell projection</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0991">Mental retardation</keyword>
<keyword id="KW-0524">Neurogenesis</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0702">S-nitrosylation</keyword>
<keyword id="KW-0770">Synapse</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0879">Wnt signaling pathway</keyword>
<feature type="initiator methionine" description="Removed" evidence="12">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Catenin beta-1" id="PRO_0000064271">
<location>
<begin position="2"/>
<end position="781"/>
</location>
</feature>
<feature type="repeat" description="ARM 1">
<location>
<begin position="151"/>
<end position="191"/>
</location>
</feature>
<feature type="repeat" description="ARM 2">
<location>
<begin position="193"/>
<end position="234"/>
</location>
</feature>
<feature type="repeat" description="ARM 3">
<location>
<begin position="235"/>
<end position="276"/>
</location>
</feature>
<feature type="repeat" description="ARM 4">
<location>
<begin position="277"/>
<end position="318"/>
</location>
</feature>
<feature type="repeat" description="ARM 5">
<location>
<begin position="319"/>
<end position="360"/>
</location>
</feature>
<feature type="repeat" description="ARM 6">
<location>
<begin position="361"/>
<end position="389"/>
</location>
</feature>
<feature type="repeat" description="ARM 7">
<location>
<begin position="400"/>
<end position="441"/>
</location>
</feature>
<feature type="repeat" description="ARM 8">
<location>
<begin position="442"/>
<end position="484"/>
</location>
</feature>
<feature type="repeat" description="ARM 9">
<location>
<begin position="489"/>
<end position="530"/>
</location>
</feature>
<feature type="repeat" description="ARM 10">
<location>
<begin position="531"/>
<end position="571"/>
</location>
</feature>
<feature type="repeat" description="ARM 11">
<location>
<begin position="594"/>
<end position="636"/>
</location>
</feature>
<feature type="repeat" description="ARM 12">
<location>
<begin position="637"/>
<end position="666"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with VCL" evidence="14">
<location>
<begin position="2"/>
<end position="23"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with BCL9" evidence="49">
<location>
<begin position="156"/>
<end position="178"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with SCRIB" evidence="14">
<location>
<begin position="772"/>
<end position="781"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="12">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by GSK3-beta; alternate" evidence="33">
<location>
<position position="23"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by GSK3-beta" evidence="33">
<location>
<position position="29"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by GSK3-beta and HIPK2" evidence="63 74">
<location>
<position position="33"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by GSK3-beta and HIPK2" evidence="63">
<location>
<position position="37"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by GSK3-beta" evidence="33">
<location>
<position position="41"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="34">
<location>
<position position="45"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="73">
<location>
<position position="49"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by PTK6" evidence="61">
<location>
<position position="64"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by CSK" evidence="24">
<location>
<position position="86"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by FYN and PTK6" evidence="41 61">
<location>
<position position="142"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK5" evidence="11 13 47">
<location>
<position position="191"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK5" evidence="47">
<location>
<position position="246"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by PTK6" evidence="61">
<location>
<position position="331"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by PTK6" evidence="93">
<location>
<position position="333"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 13">
<location>
<position position="552"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="9">
<location>
<position position="556"/>
</location>
</feature>
<feature type="modified residue" description="S-nitrosocysteine" evidence="16">
<location>
<position position="619"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by CSK" evidence="24">
<location>
<position position="654"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 9 10">
<location>
<position position="675"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GlcNAc) serine; alternate" evidence="72">
<location>
<position position="23"/>
</location>
</feature>
<feature type="sequence variant" description="In hepatocellular carcinoma; no effect; dbSNP:rs1413975856." id="VAR_017612" evidence="20 33">
<original>S</original>
<variation>R</variation>
<location>
<position position="23"/>
</location>
</feature>
<feature type="sequence variant" description="In hepatocellular carcinoma." id="VAR_017613" evidence="20">
<location>
<begin position="25"/>
<end position="33"/>
</location>
</feature>
<feature type="sequence variant" description="In hepatocellular carcinoma; dbSNP:rs121913396." id="VAR_017614" evidence="20">
<original>D</original>
<variation>A</variation>
<location>
<position position="32"/>
</location>
</feature>
<feature type="sequence variant" description="In PTR and hepatocellular carcinoma; dbSNP:rs121913396." id="VAR_017615" evidence="17 20">
<original>D</original>
<variation>G</variation>
<location>
<position position="32"/>
</location>
</feature>
<feature type="sequence variant" description="In PTR, hepatoblastoma and hepatocellular carcinoma; dbSNP:rs28931588." id="VAR_017616" evidence="17 20 29 90">
<original>D</original>
<variation>Y</variation>
<location>
<position position="32"/>
</location>
</feature>
<feature type="sequence variant" description="In PTR, MDB and hepatocellular carcinoma; dbSNP:rs121913400." id="VAR_017617" evidence="17 20 22">
<original>S</original>
<variation>F</variation>
<location>
<position position="33"/>
</location>
</feature>
<feature type="sequence variant" description="In hepatocellular carcinoma." id="VAR_017618" evidence="20">
<original>S</original>
<variation>L</variation>
<location>
<position position="33"/>
</location>
</feature>
<feature type="sequence variant" description="In colorectal cancer and PTR; constitutively active Wnt signaling pathway; enhances transactivation of target genes; dbSNP:rs121913400." id="VAR_017619" evidence="17 33 84 89">
<original>S</original>
<variation>Y</variation>
<location>
<position position="33"/>
</location>
</feature>
<feature type="sequence variant" description="In PTR; dbSNP:rs28931589." id="VAR_017620" evidence="17">
<original>G</original>
<variation>E</variation>
<location>
<position position="34"/>
</location>
</feature>
<feature type="sequence variant" description="In hepatocellular carcinoma; dbSNP:rs121913399." id="VAR_017621" evidence="20">
<original>G</original>
<variation>R</variation>
<location>
<position position="34"/>
</location>
</feature>
<feature type="sequence variant" description="In hepatoblastoma; dbSNP:rs28931589." id="VAR_017622" evidence="90">
<original>G</original>
<variation>V</variation>
<location>
<position position="34"/>
</location>
</feature>
<feature type="sequence variant" description="In hepatocellular carcinoma." id="VAR_017623" evidence="20">
<original>I</original>
<variation>S</variation>
<location>
<position position="35"/>
</location>
</feature>
<feature type="sequence variant" description="In hepatocellular carcinoma." id="VAR_017628" evidence="20">
<original>SG</original>
<variation>W</variation>
<location>
<begin position="37"/>
<end position="38"/>
</location>
</feature>
<feature type="sequence variant" description="In MDB and hepatocellular carcinoma; enhances transactivation of target genes; dbSNP:rs121913228." id="VAR_017624" evidence="20 22 33">
<original>S</original>
<variation>A</variation>
<location>
<position position="37"/>
</location>
</feature>
<feature type="sequence variant" description="In PTR, hepatoblastoma and ovarian cancer; dbSNP:rs121913403." id="VAR_017625" evidence="17 18 90">
<original>S</original>
<variation>C</variation>
<location>
<position position="37"/>
</location>
</feature>
<feature type="sequence variant" description="In PTR; dbSNP:rs121913403." id="VAR_017626" evidence="17">
<original>S</original>
<variation>F</variation>
<location>
<position position="37"/>
</location>
</feature>
<feature type="sequence variant" description="In hepatocellular carcinoma; dbSNP:rs121913403." id="VAR_017627" evidence="20">
<original>S</original>
<variation>Y</variation>
<location>
<position position="37"/>
</location>
</feature>
<feature type="sequence variant" description="In hepatoblastoma and hepatocellular carcinoma; also in a desmoid tumor; strongly reduces phosphorylation and degradation; abolishes phosphorylation on Ser-33 and Ser-37 and enhances transactivation of target genes; dbSNP:rs121913412." id="VAR_017629" evidence="18 19 20 21 33 34 90">
<original>T</original>
<variation>A</variation>
<location>
<position position="41"/>
</location>
</feature>
<feature type="sequence variant" description="In PTR, hepatocellular carcinoma and ovarian cancer; dbSNP:rs121913413." id="VAR_017630" evidence="17 18 20">
<original>T</original>
<variation>I</variation>
<location>
<position position="41"/>
</location>
</feature>
<feature type="sequence variant" description="In hepatocellular carcinoma; dbSNP:rs121913409." id="VAR_017631" evidence="20">
<original>S</original>
<variation>F</variation>
<location>
<position position="45"/>
</location>
</feature>
<feature type="sequence variant" description="In hepatocellular carcinoma; dbSNP:rs121913407." id="VAR_017632" evidence="20">
<original>S</original>
<variation>P</variation>
<location>
<position position="45"/>
</location>
</feature>
<feature type="sequence variant" description="In colorectal cancer." id="VAR_055430" evidence="89">
<location>
<position position="45"/>
</location>
</feature>
<feature type="sequence variant" description="In NEDSDV." id="VAR_072282" evidence="77">
<original>L</original>
<variation>P</variation>
<location>
<position position="388"/>
</location>
</feature>
<feature type="sequence variant" description="In NEDSDV; the patient also manifest features of exudative vitreoretinopathy." id="VAR_079199" evidence="80">
<location>
<begin position="558"/>
<end position="781"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4135384." id="VAR_018954" evidence="91">
<original>M</original>
<variation>V</variation>
<location>
<position position="688"/>
</location>
</feature>
<feature type="sequence variant" description="In EVR7; unknown pathological significance; dbSNP:rs748653573." id="VAR_079200" evidence="81">
<original>R</original>
<variation>C</variation>
<location>
<position position="710"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect." evidence="33">
<original>S</original>
<variation>F</variation>
<location>
<position position="29"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation by PTK6." evidence="61">
<original>Y</original>
<variation>F</variation>
<location>
<position position="64"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with BCL9 and BCL9L." evidence="49">
<original>Y</original>
<variation>E</variation>
<location>
<position position="142"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with BCL9 but no effect on interaction with CDH3; when associated with A-159." evidence="49">
<original>L</original>
<variation>A</variation>
<location>
<position position="156"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with BCL9 and CDH3. Abolishes interaction with BCL9 but no effect on interaction with CDH3; when associated with A-156." evidence="49">
<original>L</original>
<variation>A</variation>
<location>
<position position="159"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with BCL9 and CDH3." evidence="49">
<original>L</original>
<variation>A</variation>
<location>
<position position="178"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes or strongly reduces AXIN2 binding." evidence="23">
<original>F</original>
<variation>A</variation>
<location>
<position position="253"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes or strongly reduces AXIN1 and AXIN2 binding. Strongly reduces phosphorylation and degradation; when associated with A-386 and A-383." evidence="23">
<original>H</original>
<variation>A</variation>
<location>
<position position="260"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes or strongly reduces AXIN1 and AXIN2 binding." evidence="23">
<original>K</original>
<variation>A</variation>
<location>
<position position="292"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes TCF7L2 binding." evidence="30">
<original>K</original>
<variation>E</variation>
<location>
<position position="312"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes APC binding." evidence="23">
<original>K</original>
<variation>A</variation>
<location>
<position position="345"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes APC binding. Strongly reduces phosphorylation and degradation; when associated with A-260 and A-386." evidence="23">
<original>W</original>
<variation>A</variation>
<location>
<position position="383"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces APC binding. Strongly reduces phosphorylation and degradation; when associated with A-260 and A-383." evidence="23">
<original>R</original>
<variation>A</variation>
<location>
<position position="386"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes TCF7L2 and LEF1 binding." evidence="23">
<original>N</original>
<variation>A</variation>
<location>
<position position="426"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces or abolishes LEF1 binding." evidence="23 30">
<original>K</original>
<variation>A</variation>
<location>
<position position="435"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes TCF7L2 binding." evidence="23 30">
<original>K</original>
<variation>E</variation>
<location>
<position position="435"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes TCF7L2 binding, and strongly reduces or abolishes LEF1 binding." evidence="23">
<original>R</original>
<variation>A</variation>
<location>
<position position="469"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes TCF7L2 binding, and strongly reduces or abolishes LEF1 binding." evidence="23">
<original>H</original>
<variation>A</variation>
<location>
<position position="470"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes TCF7L2 and LEF1 binding." evidence="23">
<original>K</original>
<variation>A</variation>
<location>
<position position="508"/>
</location>
</feature>
<feature type="mutagenesis site" description="Enhances TBP binding and transactivation of target genes." evidence="24">
<original>Y</original>
<variation>E</variation>
<location>
<position position="654"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes increase of TBP binding after phosphorylation by CSK." evidence="24">
<original>Y</original>
<variation>F</variation>
<location>
<position position="654"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes CTNNBIP1 binding; when associated with A-661." evidence="38">
<original>F</original>
<variation>A</variation>
<location>
<position position="660"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes CTNNBIP1 binding; when associated with A-660." evidence="38">
<original>R</original>
<variation>A</variation>
<location>
<position position="661"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="135"/>
<end position="150"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="152"/>
<end position="160"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="165"/>
<end position="179"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="182"/>
<end position="189"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="192"/>
<end position="204"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="208"/>
<end position="221"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="225"/>
<end position="233"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="236"/>
<end position="243"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="249"/>
<end position="265"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="269"/>
<end position="276"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="278"/>
<end position="284"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="285"/>
<end position="287"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="291"/>
<end position="305"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="309"/>
<end position="317"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="320"/>
<end position="330"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="334"/>
<end position="347"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="353"/>
<end position="359"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="362"/>
<end position="367"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="368"/>
<end position="371"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="375"/>
<end position="389"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="399"/>
<end position="408"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="414"/>
<end position="427"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="428"/>
<end position="430"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="432"/>
<end position="440"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="443"/>
<end position="454"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="458"/>
<end position="471"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="473"/>
<end position="475"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="478"/>
<end position="487"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="491"/>
<end position="496"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="499"/>
<end position="501"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="504"/>
<end position="517"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="521"/>
<end position="523"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="524"/>
<end position="529"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="532"/>
<end position="547"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="550"/>
<end position="552"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="554"/>
<end position="557"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="561"/>
<end position="563"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="566"/>
<end position="580"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="584"/>
<end position="592"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="596"/>
<end position="601"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="602"/>
<end position="604"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="608"/>
<end position="621"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="625"/>
<end position="633"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="637"/>
<end position="642"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="643"/>
<end position="645"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="649"/>
<end position="662"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="663"/>
<end position="665"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="668"/>
<end position="682"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="688"/>
<end position="690"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="778"/>
<end position="780"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1G3J"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1JDH"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1QZ7"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1T08"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2Z6H"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3DIW"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4DJS"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18220336"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000250"/>
<evidence key="15" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="B6V8E6"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q02248"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10192393"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10391090"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10398436"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10435629"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10655994"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10666372"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10966653"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11279024"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11389839"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11389840"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11464291"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11590244"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11703283"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11713475"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11713476"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11751639"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12027456"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12051714"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12077367"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12297051"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12370829"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12408824"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12420223"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12501215"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12640114"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12712206"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12830000"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14595118"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16424001"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16858403"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17009320"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17047063"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17052462"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17289029"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17524503"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18077326"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18086858"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18378692"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18819930"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18957423"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19433865"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19693690"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19816403"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19996314"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20026641"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20164195"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20307497"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21132015"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21247902"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21262353"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21623382"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22155184"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22647378"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22699938"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23033978"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24342833"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24824780"/>
</source>
</evidence>
<evidence key="74" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25169422"/>
</source>
</evidence>
<evidence key="75" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25183871"/>
</source>
</evidence>
<evidence key="76" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25266658"/>
</source>
</evidence>
<evidence key="77" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25326669"/>
</source>
</evidence>
<evidence key="78" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25807484"/>
</source>
</evidence>
<evidence key="79" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28051089"/>
</source>
</evidence>
<evidence key="80" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28514307"/>
</source>
</evidence>
<evidence key="81" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28575650"/>
</source>
</evidence>
<evidence key="82" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28829046"/>
</source>
</evidence>
<evidence key="83" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29367600"/>
</source>
</evidence>
<evidence key="84" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29374064"/>
</source>
</evidence>
<evidence key="85" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29432739"/>
</source>
</evidence>
<evidence key="86" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29739711"/>
</source>
</evidence>
<evidence key="87" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="31073040"/>
</source>
</evidence>
<evidence key="88" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7982500"/>
</source>
</evidence>
<evidence key="89" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9065402"/>
</source>
</evidence>
<evidence key="90" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9927029"/>
</source>
</evidence>
<evidence key="91" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="92" type="ECO:0000305"/>
<evidence key="93" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="20026641"/>
</source>
</evidence>
<evidence key="94" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="31073040"/>
</source>
</evidence>
<sequence length="781" mass="85497" checksum="CB78F165A3EEF86E" modified="1994-02-01" version="1">MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPELTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

